POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1rjb	FL CYTOKINE RECEPTOR (Homo sapiens)	7 / 12	LEU A 616 GLY A 617 VAL A 624 ALA A 642 GLU A 661 CYH A 694 CYH A 828	None	0.87A	48.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1rjb	FL CYTOKINE RECEPTOR (Homo sapiens)	7 / 12	LEU A 616 VAL A 624 ALA A 642 GLU A 661 CYH A 694 GLY A 697 CYH A 828	None	0.58A	48.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1s9i	DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (Homo sapiens)	6 / 12	LEU A  78 VAL A  86 ALA A  99 GLY A 153 CYH A 211 PHE A 213	ATP  A 535 (-3.9A) ATP  A 535 (-4.1A) ATP  A 535 (-3.6A) ATP  A 535 ( 4.7A) ATP  A 535 ( 4.5A) 5EA  A1001 (-3.6A)	0.67A	24.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 LEU A 644 CYH A 673 GLY A 676 CYH A 809	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A)	0.51A	53.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	5 / 12	LEU A 344 VAL A 352 ALA A 367 GLU A 386 GLY A 420	STU  A 100 (-3.8A) STU  A 100 (-4.8A) STU  A 100 (-3.2A) None STU  A 100 (-3.5A)	0.54A	33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1zlt	SERINE/THREONINE-PRO TEIN KINASE CHK1 (Homo sapiens)	6 / 12	LEU A  15 VAL A  23 ALA A  36 GLU A  55 CYH A  87 GLY A  90	HYM  A 400 (-4.2A) HYM  A 400 (-4.3A) HYM  A 400 (-3.5A) None HYM  A 400 (-4.2A) None	0.59A	26.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	5 / 12	LEU X  17 VAL X  25 ALA X  37 GLU X  54 GLY X  88	STU  X 902 (-3.8A) STU  X 902 ( 4.8A) STU  X 902 (-3.1A) STU  X 902 ( 4.4A) STU  X 902 (-3.5A)	0.45A	35.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2hw6	MAP KINASE-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 1 (Homo sapiens)	6 / 12	LEU A  55 VAL A  63 ALA A  76 GLY A 130 CYH A 190 PHE A 230	None	0.94A	26.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2hz0	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	5 / 12	LEU A 248 VAL A 256 ALA A 269 GLU A 286 GLY A 321	GIN  A 600 ( 4.6A) GIN  A 600 ( 4.7A) GIN  A 600 (-3.1A) GIN  A 600 (-3.6A) None	0.39A	38.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2iwi	SERINE/THREONINE-PRO TEIN KINASE PIM-2 (Homo sapiens)	6 / 12	LEU A  38 GLY A  39 VAL A  46 ALA A  59 GLU A  83 LEU A  87	HB1  A1289 ( 4.1A) HB1  A1289 (-3.1A) HB1  A1289 (-3.6A) HB1  A1289 ( 3.7A) None None	0.87A	23.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 CYH A 666 GLY A 669	None	0.58A	50.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2psq	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 GLU A 534 VAL A 564 GLY A 570	None	0.46A	48.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2r4b	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4 (Homo sapiens)	5 / 12	LEU A 724 VAL A 732 ALA A 749 GLY A 802 PHE A 862	GW7  A   1 ( 4.2A) GW7  A   1 ( 4.8A) GW7  A   1 (-3.3A) GW7  A   1 (-3.6A) GW7  A   1 (-3.8A)	0.50A	33.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2xik	SERINE/THREONINE PROTEIN KINASE 25 (Homo sapiens)	5 / 12	VAL A  34 ALA A  47 GLU A  66 LEU A  70 GLY A 101	J60  A1294 ( 4.9A) J60  A1294 (-3.3A) None None J60  A1294 ( 3.8A)	0.50A	26.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2z2w	WEE1-LIKE PROTEIN KINASE (Homo sapiens)	5 / 12	VAL A 313 ALA A 326 GLU A 346 CYH A 379 GLY A 382	770  A 901 ( 4.7A) 770  A 901 (-3.5A) 770  A 901 (-3.9A) 770  A 901 (-3.9A) 770  A 901 (-3.4A)	0.49A	27.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2z8c	INSULIN RECEPTOR (Homo sapiens)	5 / 12	LEU A1002 VAL A1010 ALA A1028 GLU A1047 GLY A1082	S91  A   1 ( 4.1A) S91  A   1 ( 4.9A) S91  A   1 (-3.2A) None S91  A   1 (-3.3A)	0.52A	36.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3a62	RIBOSOMAL PROTEIN S6 KINASE BETA-1 (Homo sapiens)	6 / 12	LEU A  97 VAL A 105 ALA A 121 GLU A 143 LEU A 147 GLY A 178	STU  A 400 (-3.8A) STU  A 400 (-4.9A) STU  A 400 (-3.1A) STU  A 400 ( 4.3A) None STU  A 400 ( 4.4A)	0.52A	26.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	6 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 GLU A 534 VAL A 564	M33  A1996 (-4.0A) M33  A1996 ( 3.8A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None None	1.05A	53.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	6 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 VAL A 564 PHE A 645	M33  A1996 (-4.0A) M33  A1996 ( 3.8A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None None	1.10A	53.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	6 / 12	LEU A 487 VAL A 495 ALA A 515 VAL A 564 GLY A 570 PHE A 645	M33  A1996 (-4.0A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None M33  A1996 ( 4.8A) None	0.80A	53.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	8 / 12	LEU A 484 GLY A 485 VAL A 492 ALA A 512 GLU A 531 VAL A 561 GLY A 567 PHE A 642	C4F  A   1 ( 3.9A) C4F  A   1 ( 4.5A) None C4F  A   1 (-3.3A) None C4F  A   1 ( 4.8A) None C4F  A   1 ( 4.5A)	0.73A	55.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	LEU A 484 VAL A 492 ALA A 512 GLU A 531 VAL A 561 GLY A 567 LEU A 644	C4F  A   1 ( 3.9A) None C4F  A   1 (-3.3A) None C4F  A   1 ( 4.8A) None None	0.79A	55.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3hng	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	LEU A 833 GLY A 834 ALA A 859 GLU A 878 LEU A 882 VAL A 909 CYH A1039	8ST  A2001 ( 4.7A) None 8ST  A2001 ( 3.8A) 8ST  A2001 (-3.7A) None 8ST  A2001 (-4.1A) 8ST  A2001 (-4.2A)	0.87A	67.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3hng	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	9 / 12	LEU A 833 VAL A 841 ALA A 859 GLU A 878 LEU A 882 VAL A 909 CYH A 912 GLY A 915 CYH A1039	8ST  A2001 ( 4.7A) 8ST  A2001 ( 4.6A) 8ST  A2001 ( 3.8A) 8ST  A2001 (-3.7A) None 8ST  A2001 (-4.1A) 8ST  A2001 (-3.8A) None 8ST  A2001 (-4.2A)	0.52A	67.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	5 / 12	LEU A  39 VAL A  47 ALA A  60 LEU A  84 GLY A 116	QUE  A   1 ( 3.8A) QUE  A   1 ( 4.6A) QUE  A   1 (-3.2A) QUE  A   1 ( 4.6A) None	0.51A	25.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 12	LEU A  49 VAL A  57 ALA A  70 LEU A  95 GLY A 126	XFE  A 351 (-4.2A) XFE  A 351 ( 4.5A) XFE  A 351 (-3.2A) None None	0.43A	22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3nuu	PKB-LIKE (Homo sapiens)	5 / 12	LEU A  88 VAL A  96 ALA A 109 GLU A 130 GLY A 165	JOZ  A 361 (-4.1A) JOZ  A 361 ( 4.7A) JOZ  A 361 (-3.4A) SO4  A   5 (-3.1A) None	0.51A	26.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3nyo	G PROTEIN-COUPLED RECEPTOR KINASE 6 (Homo sapiens)	5 / 12	LEU A 192 VAL A 200 ALA A 213 LEU A 238 GLY A 269	AMP  A 577 ( 4.3A) AMP  A 577 (-4.3A) AMP  A 577 (-3.4A) None None	0.47A	21.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	6 / 12	LEU A 484 GLY A 485 ALA A 512 GLU A 531 VAL A 561 PHE A 642	07J  A   1 ( 4.3A) 07J  A   1 ( 4.9A) 07J  A   1 (-3.5A) 07J  A   1 (-3.8A) 07J  A   1 (-4.7A) 07J  A   1 ( 4.6A)	0.98A	46.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	LEU A 484 VAL A 492 ALA A 512 GLU A 531 VAL A 561 GLY A 567 LEU A 644	07J  A   1 ( 4.3A) 07J  A   1 (-4.0A) 07J  A   1 (-3.5A) 07J  A   1 (-3.8A) 07J  A   1 (-4.7A) 07J  A   1 (-3.7A) None	0.75A	46.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	LEU A 484 VAL A 492 ALA A 512 GLU A 531 VAL A 561 GLY A 567 PHE A 642	07J  A   1 ( 4.3A) 07J  A   1 (-4.0A) 07J  A   1 (-3.5A) 07J  A   1 (-3.8A) 07J  A   1 (-4.7A) 07J  A   1 (-3.7A) 07J  A   1 ( 4.6A)	0.61A	46.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	5 / 12	LEU A 361 VAL A 369 ALA A 382 LEU A 407 GLY A 439	07U  A   1 ( 4.8A) 07U  A   1 (-4.8A) 07U  A   1 (-3.3A) None None	0.46A	24.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3vid	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	8 / 12	LEU A 840 GLY A 841 ALA A 866 GLU A 885 LEU A 889 VAL A 916 CYH A 919 CYH A1045	4TT  A2001 ( 4.0A) 4TT  A2001 ( 4.8A) 4TT  A2001 (-3.5A) None None None 4TT  A2001 (-4.3A) None	0.79A	85.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3vid	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	9 / 12	LEU A 840 VAL A 848 ALA A 866 GLU A 885 LEU A 889 VAL A 916 CYH A 919 GLY A 922 CYH A1045	4TT  A2001 ( 4.0A) 4TT  A2001 ( 4.5A) 4TT  A2001 (-3.5A) None None None 4TT  A2001 (-4.3A) 4TT  A2001 (-3.7A) None	0.47A	85.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4agd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	8 / 12	LEU A 840 GLY A 841 ALA A 866 GLU A 885 LEU A 889 VAL A 916 CYH A 919 CYH A1045	B49  A2000 (-3.7A) B49  A2000 ( 4.6A) B49  A2000 (-3.5A) None None B49  A2000 (-4.8A) B49  A2000 (-4.2A) B49  A2000 ( 4.1A)	0.79A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4agd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	9 / 12	LEU A 840 VAL A 848 ALA A 866 GLU A 885 LEU A 889 VAL A 916 CYH A 919 GLY A 922 CYH A1045	B49  A2000 (-3.7A) None B49  A2000 (-3.5A) None None B49  A2000 (-4.8A) B49  A2000 (-4.2A) B49  A2000 ( 3.7A) B49  A2000 ( 4.1A)	0.49A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4agu	CYCLIN-DEPENDENT KINASE-LIKE 1 (Homo sapiens)	6 / 12	GLY A  11 ALA A  31 GLU A  51 LEU A  55 CYH A  83 CYH A 143	D15  A 500 (-3.8A) D15  A 500 (-3.4A) None None D15  A 500 (-4.3A) D15  A 500 ( 4.0A)	0.77A	27.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4agu	CYCLIN-DEPENDENT KINASE-LIKE 1 (Homo sapiens)	6 / 12	VAL A  18 ALA A  31 GLU A  51 LEU A  55 CYH A  83 CYH A 143	D15  A 500 (-4.6A) D15  A 500 (-3.4A) None None D15  A 500 (-4.3A) D15  A 500 ( 4.0A)	0.68A	27.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4at3	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	6 / 12	LEU A 560 GLY A 561 VAL A 568 ALA A 586 GLY A 639 PHE A 711	LTI  A1839 ( 4.2A) LTI  A1839 ( 4.3A) None LTI  A1839 (-3.3A) LTI  A1839 (-3.4A) None	0.66A	35.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4bc6	SERINE/THREONINE-PRO TEIN KINASE 10 (Homo sapiens)	6 / 12	LEU A  42 VAL A  50 ALA A  63 LEU A  85 CYH A 113 GLY A 116	XZN  A1317 (-3.6A) XZN  A1317 ( 4.7A) XZN  A1317 (-3.5A) None XZN  A1317 (-3.7A) XZN  A1317 ( 3.7A)	0.64A	27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4eut	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	6 / 12	LEU A  15 VAL A  23 ALA A  36 GLU A  55 LEU A  59 CYH A  89	BX7  A 401 (-3.7A) BX7  A 401 (-4.4A) BX7  A 401 (-3.4A) None None BX7  A 401 (-4.1A)	0.59A	22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4eut	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	6 / 12	LEU A  15 VAL A  23 ALA A  36 LEU A  59 CYH A  89 GLY A  92	BX7  A 401 (-3.7A) BX7  A 401 (-4.4A) BX7  A 401 (-3.4A) None BX7  A 401 (-4.1A) BX7  A 401 (-3.5A)	0.49A	22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4euu	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	7 / 12	LEU A  15 VAL A  23 ALA A  36 GLU A  55 LEU A  59 CYH A  89 GLY A  92	BX7  A 401 (-3.9A) BX7  A 401 ( 4.6A) BX7  A 401 (-3.4A) None None BX7  A 401 (-4.1A) BX7  A 401 (-3.3A)	0.57A	25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4gv1	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	6 / 12	LEU A 156 VAL A 164 ALA A 177 GLU A 198 LEU A 202 GLY A 233	0XZ  A 501 ( 4.1A) 0XZ  A 501 (-4.5A) 0XZ  A 501 (-3.3A) GOL  A 503 (-3.6A) None None	0.61A	26.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4hvi	TYROSINE-PROTEIN KINASE JAK3 (Homo sapiens)	6 / 12	LEU A 828 VAL A 836 ALA A 853 GLU A 871 LEU A 875 GLY A 908	19S  A1201 (-3.9A) 19S  A1201 (-4.4A) 19S  A1201 (-3.3A) None None 19S  A1201 ( 3.8A)	0.59A	35.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4hzs	ACTIVATED CDC42 KINASE 1 (Homo sapiens)	5 / 12	LEU A 132 VAL A 140 ALA A 156 GLY A 211 PHE A 271	None	0.50A	33.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4jxf	SERINE/THREONINE-PRO TEIN KINASE PLK4 (Homo sapiens)	6 / 12	LEU A  18 VAL A  26 ALA A  39 CYH A  92 GLY A  95 PHE A 155	631  A 301 (-3.4A) 631  A 301 (-4.6A) 631  A 301 (-3.3A) 631  A 301 (-4.5A) 631  A 301 ( 3.7A) None	0.29A	26.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	6 / 12	LEU A 478 VAL A 486 ALA A 506 GLU A 525 VAL A 555 GLY A 561	ACP  A 801 (-3.8A) ACP  A 801 (-4.2A) ACP  A 801 (-3.3A) ACP  A 801 ( 4.8A) ACP  A 801 (-4.7A) ACP  A 801 ( 4.6A)	0.68A	51.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4lg4	SERINE/THREONINE-PRO TEIN KINASE 3 (Homo sapiens)	5 / 12	LEU A  33 VAL A  41 ALA A  54 CYH A 102 GLY A 105	GOL  A 404 ( 3.6A) GOL  A 404 (-4.5A) GOL  A 404 ( 3.1A) GOL  A 403 (-4.0A) GOL  A 404 (-3.6A)	0.37A	27.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4o38	CYCLIN-G-ASSOCIATED KINASE (Homo sapiens)	6 / 12	LEU A  46 ALA A  67 CYH A 126 GLY A 128 CYH A 190 PHE A 192	SIN  A 401 ( 3.9A) SIN  A 401 ( 3.7A) SIN  A 401 (-4.3A) SIN  A 401 (-3.5A) None None	0.92A	24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4o38	CYCLIN-G-ASSOCIATED KINASE (Homo sapiens)	7 / 12	LEU A  46 VAL A  54 ALA A  67 GLU A  85 CYH A 126 GLY A 128 CYH A 190	SIN  A 401 ( 3.9A) None SIN  A 401 ( 3.7A) None SIN  A 401 (-4.3A) SIN  A 401 (-3.5A) None	0.79A	24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4oli	NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (Homo sapiens)	6 / 12	LEU A 903 VAL A 911 ALA A 928 GLU A 947 LEU A 951 GLY A 984	2TT  A1202 (-3.5A) 2TT  A1202 (-4.5A) 2TT  A1202 ( 3.9A) None None 2TT  A1202 (-3.4A)	0.57A	21.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4rt7	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	6 / 12	LEU A 616 GLY A 617 ALA A 642 GLU A 661 CYH A 694 CYH A 828	P30  A1001 (-3.8A) None P30  A1001 (-3.4A) P30  A1001 (-3.6A) None P30  A1001 (-4.1A)	0.78A	40.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4rt7	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 VAL A 624 ALA A 642 GLU A 661 CYH A 694 GLY A 697 CYH A 828	P30  A1001 (-3.8A) None P30  A1001 (-3.4A) P30  A1001 (-3.6A) None P30  A1001 (-3.4A) P30  A1001 (-4.1A)	0.46A	40.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	5 / 12	LEU A 104 VAL A 112 ALA A 125 LEU A 150 GLY A 181	ATP  A 501 ( 4.3A) ATP  A 501 (-4.0A) ATP  A 501 (-3.4A) None None	0.51A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4wsq	AP2-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	6 / 12	LEU A  52 VAL A  60 ALA A  72 CYH A 129 GLY A 132 CYH A 193	KSA  A 405 ( 4.0A) KSA  A 405 ( 4.9A) KSA  A 405 (-3.2A) KSA  A 405 (-4.5A) KSA  A 405 (-3.5A) KSA  A 405 (-3.4A)	0.53A	23.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xcu	FIBROBLAST GROWTH FACTOR RECEPTOR 4 (Homo sapiens)	6 / 12	LEU A 473 GLY A 474 ALA A 501 GLU A 520 VAL A 550 PHE A 631	40M  A1002 ( 4.6A) None 40M  A1002 ( 4.1A) 40M  A1002 (-3.7A) 40M  A1002 (-4.7A) 40M  A1002 ( 4.2A)	1.00A	51.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xcu	FIBROBLAST GROWTH FACTOR RECEPTOR 4 (Homo sapiens)	7 / 12	LEU A 473 VAL A 481 ALA A 501 GLU A 520 VAL A 550 GLY A 556 LEU A 633	40M  A1002 ( 4.6A) 40M  A1002 ( 4.5A) 40M  A1002 ( 4.1A) 40M  A1002 (-3.7A) 40M  A1002 (-4.7A) 40M  A1002 ( 3.7A) None	0.75A	51.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xcu	FIBROBLAST GROWTH FACTOR RECEPTOR 4 (Homo sapiens)	7 / 12	LEU A 473 VAL A 481 ALA A 501 GLU A 520 VAL A 550 GLY A 556 PHE A 631	40M  A1002 ( 4.6A) 40M  A1002 ( 4.5A) 40M  A1002 ( 4.1A) 40M  A1002 (-3.7A) 40M  A1002 (-4.7A) 40M  A1002 ( 3.7A) 40M  A1002 ( 4.2A)	0.66A	51.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	6 / 12	LEU A 616 VAL A 624 ALA A 642 CYH A 694 GLY A 697 CYH A 828	P30  A1001 (-4.0A) P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 (-4.2A) P30  A1001 (-3.5A) P30  A1001 (-4.8A)	0.45A	52.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	6 / 12	VAL A 624 ALA A 642 GLU A 661 CYH A 694 GLY A 697 CYH A 828	P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 (-3.1A) P30  A1001 (-4.2A) P30  A1001 (-3.5A) P30  A1001 (-4.8A)	0.51A	52.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4z7g	SERINE/THREONINE-PRO TEIN KINASE/ENDORIBONUCLE ASE IRE1 (Homo sapiens)	6 / 12	LEU A 577 GLY A 578 ALA A 597 GLU A 612 LEU A 616 CYH A 645	None	0.79A	22.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	6 / 12	LEU A 484 GLY A 485 ALA A 512 GLU A 531 VAL A 561 PHE A 642	38O  A1769 (-3.2A) 38O  A1769 ( 4.7A) 38O  A1769 (-3.6A) EDO  A1766 (-4.1A) 38O  A1769 (-4.3A) EDO  A1766 (-3.7A)	1.09A	45.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	7 / 12	LEU A 484 VAL A 492 ALA A 512 GLU A 531 VAL A 561 GLY A 567 LEU A 644	38O  A1769 (-3.2A) 38O  A1769 (-4.5A) 38O  A1769 (-3.6A) EDO  A1766 (-4.1A) 38O  A1769 (-4.3A) 38O  A1769 (-3.4A) None	0.84A	45.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	7 / 12	LEU A 484 VAL A 492 ALA A 512 GLU A 531 VAL A 561 GLY A 567 PHE A 642	38O  A1769 (-3.2A) 38O  A1769 (-4.5A) 38O  A1769 (-3.6A) EDO  A1766 (-4.1A) 38O  A1769 (-4.3A) 38O  A1769 (-3.4A) EDO  A1766 (-3.7A)	0.64A	45.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5f1z	NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (Homo sapiens)	6 / 12	LEU A 903 VAL A 911 ALA A 928 GLU A 947 LEU A 951 GLY A 984	5U3  A1200 (-3.8A) 5U3  A1200 ( 4.4A) 5U3  A1200 (-3.5A) None None 5U3  A1200 (-3.2A)	0.52A	31.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 GLY A 731 ALA A 756 GLU A 775 LEU A 779 VAL A 804	PP1  A2012 (-4.6A) PP1  A2012 ( 3.9A) PP1  A2012 (-3.2A) PP1  A2012 (-3.5A) None PP1  A2012 (-4.5A)	0.99A	41.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 GLY A 731 ALA A 756 LEU A 779 VAL A 804 GLY A 810	PP1  A2012 (-4.6A) PP1  A2012 ( 3.9A) PP1  A2012 (-3.2A) None PP1  A2012 (-4.5A) PTR  A 809 (-2.4A)	0.80A	41.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 GLY A 731 ALA A 756 VAL A 804 GLY A 810 PHE A 893	PP1  A2012 (-4.6A) PP1  A2012 ( 3.9A) PP1  A2012 (-3.2A) PP1  A2012 (-4.5A) PTR  A 809 (-2.4A) None	0.96A	41.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 GLU A 775 LEU A 779 VAL A 804	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) PP1  A2012 (-3.5A) None PP1  A2012 (-4.5A)	0.47A	41.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 LEU A 779 VAL A 804 GLY A 810	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) None PP1  A2012 (-4.5A) PTR  A 809 (-2.4A)	0.63A	41.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 VAL A 804 GLY A 810 PHE A 893	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) PP1  A2012 (-4.5A) PTR  A 809 (-2.4A) None	0.85A	41.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5grn	PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (Homo sapiens)	7 / 12	LEU A 599 VAL A 607 ALA A 625 GLU A 644 CYH A 677 GLY A 680 CYH A 835	748  A1001 (-3.8A) 748  A1001 ( 4.7A) 748  A1001 (-3.7A) 748  A1001 (-3.3A) 748  A1001 (-4.5A) 748  A1001 ( 4.0A) 748  A1001 (-4.5A)	0.57A	49.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5i3o	BMP-2-INDUCIBLE PROTEIN KINASE (Homo sapiens)	5 / 12	LEU A  57 VAL A  65 ALA A  77 CYH A 133 GLY A 136	IDV  A 401 (-3.8A) IDV  A 401 (-4.6A) IDV  A 401 (-3.6A) IDV  A 401 (-4.6A) IDV  A 401 (-3.4A)	0.45A	25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6ao5	SERINE/THREONINE-PRO TEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A  33 VAL A  41 ALA A  54 CYH A 102 GLY A 105 PHE A 165	ANP  A 501 ( 3.8A) ANP  A 501 (-4.4A) ANP  A 501 ( 3.7A) ANP  A 501 (-4.2A) ANP  A 501 ( 4.0A) None	0.63A	23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c0t	CGMP-DEPENDENT PROTEIN KINASE 1 (Homo sapiens)	5 / 12	LEU A 366 VAL A 374 ALA A 388 GLU A 409 CYH A 441	EE4  A 701 ( 4.6A) EE4  A 701 (-4.4A) EE4  A 701 (-3.3A) DMS  A 702 ( 4.2A) EE4  A 701 (-4.6A)	0.55A	12.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c7y	TYROSINE-PROTEIN KINASE JAK1 (Homo sapiens)	6 / 12	LEU A 881 GLY A 882 ALA A 906 GLU A 925 LEU A 929 GLY A 962	ADP  A1201 ( 4.5A) ADP  A1201 (-3.5A) ADP  A1201 (-3.4A) None None ADP  A1201 ( 4.1A)	0.74A	17.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c7y	TYROSINE-PROTEIN KINASE JAK1 (Homo sapiens)	6 / 12	LEU A 881 VAL A 889 ALA A 906 GLU A 925 LEU A 929 GLY A 962	ADP  A1201 ( 4.5A) ADP  A1201 (-4.3A) ADP  A1201 (-3.4A) None None ADP  A1201 ( 4.1A)	0.69A	17.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6fek	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 GLY A 731 ALA A 756 GLU A 775 LEU A 779 VAL A 804	ADN  A1104 ( 4.0A) ADN  A1104 ( 3.9A) ADN  A1104 (-3.4A) None None ADN  A1104 ( 4.6A)	0.93A	23.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6fek	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 GLY A 731 ALA A 756 LEU A 779 VAL A 804 GLY A 810	ADN  A1104 ( 4.0A) ADN  A1104 ( 3.9A) ADN  A1104 (-3.4A) None ADN  A1104 ( 4.6A) ADN  A1104 ( 3.8A)	0.74A	23.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6fek	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 GLY A 731 ALA A 756 VAL A 804 GLY A 810 PHE A 893	ADN  A1104 ( 4.0A) ADN  A1104 ( 3.9A) ADN  A1104 (-3.4A) ADN  A1104 ( 4.6A) ADN  A1104 ( 3.8A) None	0.96A	23.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6fek	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 GLU A 775 LEU A 779 VAL A 804	ADN  A1104 ( 4.0A) ADN  A1104 (-4.4A) ADN  A1104 (-3.4A) None None ADN  A1104 ( 4.6A)	0.55A	23.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6fek	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 LEU A 779 VAL A 804 GLY A 810	ADN  A1104 ( 4.0A) ADN  A1104 (-4.4A) ADN  A1104 (-3.4A) None ADN  A1104 ( 4.6A) ADN  A1104 ( 3.8A)	0.57A	23.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1b8k	PROTEIN (NEUROTROPHIN-3) (Homo sapiens)	4 / 5	ILE A 102 VAL A  21 LEU A  19 ASP A 105	None	1.17A	15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1fq3	GRANZYME B (Homo sapiens)	4 / 5	ILE A  89 VAL A  52 LEU A  46 ASP A  50	None	1.23A	22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1gng	GLYCOGEN SYNTHASE KINASE-3 BETA (Homo sapiens)	4 / 5	LYS A  85 ILE A 100 VAL A 110 LEU A 188	None	0.59A	25.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1k2p	TYROSINE-PROTEIN KINASE BTK (Homo sapiens)	4 / 5	LYS A 430 VAL A 458 LEU A 528 ASP A 539	None	0.92A	34.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1snx	TYROSINE-PROTEIN KINASE ITK/TSK (Homo sapiens)	4 / 5	LYS A 391 VAL A 419 LEU A 489 ASP A 500	None	0.95A	33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	4 / 5	LYS A 369 ILE A 389 LEU A 468 ASP A 479	STU  A 100 ( 4.7A) None STU  A 100 (-4.5A) STU  A 100 (-3.5A)	1.13A	33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	4 / 5	LYS A 369 VAL A 399 LEU A 468 ASP A 479	STU  A 100 ( 4.7A) None STU  A 100 (-4.5A) STU  A 100 (-3.5A)	0.97A	33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1unp	RAC-ALPHA SERINE/THREONINE KINASE (Homo sapiens)	4 / 5	ILE A   6 VAL A 106 LEU A 110 ASP A  32	None	1.08A	16.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1z68	FIBROBLAST ACTIVATION PROTEIN, ALPHA SUBUNIT (Homo sapiens)	4 / 5	ILE A 286 VAL A 312 LEU A 667 ASP A 290	None	1.16A	18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1zlt	SERINE/THREONINE-PRO TEIN KINASE CHK1 (Homo sapiens)	4 / 5	ILE A  58 VAL A  68 LEU A 137 ASP A 148	None HYM  A 400 (-4.8A) HYM  A 400 (-4.5A) HYM  A 400 (-3.9A)	0.90A	26.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	4 / 5	ILE X  57 VAL X  67 LEU X 137 ASP X 148	None None STU  X 902 (-4.4A) STU  X 902 (-3.6A)	0.90A	35.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	4 / 5	LYS X  39 ILE X  57 VAL X  67 LEU X 137	STU  X 902 (-3.1A) None None STU  X 902 (-4.4A)	0.81A	35.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2hak	SERINE/THREONINE-PRO TEIN KINASE MARK1 (Homo sapiens)	4 / 5	ILE A 103 VAL A 113 LEU A 182 ASP A 193	None	1.16A	24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2hak	SERINE/THREONINE-PRO TEIN KINASE MARK1 (Homo sapiens)	4 / 5	LYS A  82 VAL A 113 LEU A 182 ASP A 193	None	1.02A	24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2obv	S-ADENOSYLMETHIONINE SYNTHETASE ISOFORM TYPE-1 (Homo sapiens)	4 / 5	LYS A 234 ILE A 196 VAL A 186 LEU A 156	None	1.08A	21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	2x18	RAC-GAMMA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	ILE A   6 VAL A 105 LEU A 109 ASP A  32	None	1.12A	18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3a62	RIBOSOMAL PROTEIN S6 KINASE BETA-1 (Homo sapiens)	4 / 5	LYS A 123 ILE A 146 VAL A 156 ASP A 236	STU  A 400 ( 4.3A) None None STU  A 400 ( 3.8A)	0.98A	26.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3dko	EPHRIN TYPE-A RECEPTOR 7 (Homo sapiens)	4 / 5	LYS A 665 ILE A 685 VAL A 695 LEU A 765	IHZ  A1001 ( 4.5A) IHZ  A1001 ( 4.6A) IHZ  A1001 ( 4.9A) IHZ  A1001 (-4.6A)	0.59A	33.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3fe3	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3 (Homo sapiens)	4 / 5	LYS A  85 VAL A 116 LEU A 185 ASP A 196	None	0.94A	25.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3g1n	E3 UBIQUITIN-PROTEIN LIGASE HUWE1 (Homo sapiens)	4 / 5	LYS A4014 ILE A4233 LEU A4062 ASP A4120	None	1.10A	20.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3hng	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	4 / 5	LYS A 861 ILE A 881 VAL A 892 LEU A1029	8ST  A2001 (-4.0A) None 8ST  A2001 ( 4.7A) None	0.84A	67.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	4 / 5	ILE A 744 VAL A 753 LEU A 822 ASP A 833	None None ANP  A   1 (-4.7A) MG  A1001 ( 3.1A)	0.58A	28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3mi9	CELL DIVISION PROTEIN KINASE 9 (Homo sapiens)	4 / 5	ILE A  69 VAL A  79 LEU A 156 ASP A 167	None	1.00A	26.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3nyo	G PROTEIN-COUPLED RECEPTOR KINASE 6 (Homo sapiens)	4 / 5	ILE A 237 VAL A 247 LEU A 318 ASP A 329	None None AMP  A 577 (-4.8A) AMP  A 577 (-4.0A)	1.06A	21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	ILE A   6 VAL A 106 LEU A 110 ASP A  32	ILE  A   6 ( 0.4A) VAL  A 106 ( 0.6A) LEU  A 110 ( 0.6A) ASP  A  32 ( 0.6A)	0.88A	23.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4bc6	SERINE/THREONINE-PRO TEIN KINASE 10 (Homo sapiens)	4 / 5	ILE A  84 VAL A  94 LEU A 164 ASP A 175	None XZN  A1317 (-4.4A) XZN  A1317 (-4.7A) XZN  A1317 (-3.2A)	0.80A	27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4bc6	SERINE/THREONINE-PRO TEIN KINASE 10 (Homo sapiens)	4 / 5	LYS A  65 VAL A  94 LEU A 164 ASP A 175	XZN  A1317 (-4.1A) XZN  A1317 (-4.4A) XZN  A1317 (-4.7A) XZN  A1317 (-3.2A)	0.74A	27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4crs	SERINE/THREONINE-PRO TEIN KINASE N2 (Homo sapiens)	4 / 5	ILE A 708 VAL A 721 LEU A 789 ASP A 800	None None AGS  A1985 (-4.8A) AGS  A1985 ( 3.3A)	1.12A	25.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4crs	SERINE/THREONINE-PRO TEIN KINASE N2 (Homo sapiens)	4 / 5	LYS A 686 ILE A 708 VAL A 721 LEU A 789	AGS  A1985 (-3.0A) None None AGS  A1985 (-4.8A)	0.92A	25.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4e93	TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens)	4 / 5	ILE A 610 VAL A 620 LEU A 690 ASP A 701	None None GUI  A 901 (-4.3A) GUI  A 901 ( 4.1A)	0.80A	29.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4fmf	POLIOVIRUS RECEPTOR-RELATED PROTEIN 1 (Homo sapiens)	4 / 5	ILE A  43 VAL A  47 LEU A  49 ASP A 118	None	1.23A	19.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4fod	ALK TYROSINE KINASE RECEPTOR (Homo sapiens)	4 / 5	ILE A1170 VAL A1180 LEU A1256 ASP A1270	None 0UV  A1501 ( 4.9A) 0UV  A1501 (-4.6A) 0UV  A1501 ( 4.2A)	0.72A	34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4hvi	TYROSINE-PROTEIN KINASE JAK3 (Homo sapiens)	4 / 5	LYS A 855 ILE A 874 LEU A 956 ASP A 967	19S  A1201 (-3.5A) None 19S  A1201 (-4.5A) 19S  A1201 ( 4.1A)	1.12A	35.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4hvi	TYROSINE-PROTEIN KINASE JAK3 (Homo sapiens)	4 / 5	LYS A 855 ILE A 874 VAL A 884 LEU A 956	19S  A1201 (-3.5A) None None 19S  A1201 (-4.5A)	0.58A	35.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4ks8	SERINE/THREONINE-PRO TEIN KINASE PAK 6 (Homo sapiens)	4 / 5	LYS A 436 ILE A 455 VAL A 465 LEU A 533	None None None B49  A 701 (-4.5A)	0.91A	27.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4ks8	SERINE/THREONINE-PRO TEIN KINASE PAK 6 (Homo sapiens)	4 / 5	LYS A 436 VAL A 465 LEU A 533 ASP A 544	None None B49  A 701 (-4.5A) B49  A 701 (-4.6A)	0.76A	27.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4lg4	SERINE/THREONINE-PRO TEIN KINASE 3 (Homo sapiens)	4 / 5	ILE A  73 VAL A  83 LEU A 153 ASP A 164	None GOL  A 403 (-4.1A) GOL  A 403 ( 4.4A) GOL  A 403 (-2.4A)	0.95A	27.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4lg4	SERINE/THREONINE-PRO TEIN KINASE 3 (Homo sapiens)	4 / 5	LYS A  56 VAL A  83 LEU A 153 ASP A 164	GOL  A 403 ( 4.6A) GOL  A 403 (-4.1A) GOL  A 403 ( 4.4A) GOL  A 403 (-2.4A)	0.89A	27.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4oli	NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (Homo sapiens)	4 / 5	LYS A 930 ILE A 950 LEU A1030 ASP A1041	None None 2TT  A1202 (-4.4A) 2TT  A1202 (-4.6A)	1.16A	21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4wsq	AP2-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	4 / 5	LYS A  74 ILE A  93 VAL A 104 LEU A 183	None None None KSA  A 405 (-4.6A)	1.03A	23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xbr	PROTEIN FAM212A,SERINE/THREO NINE-PROTEIN KINASE PAK 4 (Homo sapiens)	4 / 5	ILE A 369 VAL A 379 LEU A 447 ASP A 458	None None None ATP  A 601 ( 2.5A)	0.74A	24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xbr	PROTEIN FAM212A,SERINE/THREO NINE-PROTEIN KINASE PAK 4 (Homo sapiens)	4 / 5	LYS A 350 ILE A 369 VAL A 379 ASP A 458	ATP  A 601 (-2.8A) None None ATP  A 601 ( 2.5A)	1.04A	24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4yhj	G PROTEIN-COUPLED RECEPTOR KINASE 4 (Homo sapiens)	4 / 5	ILE A 238 VAL A 248 LEU A 319 ASP A 330	None None None AN2  A 601 (-3.0A)	1.10A	20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4zg7	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOS PHODIESTERASE FAMILY MEMBER 2 (Homo sapiens)	4 / 5	LYS A 191 ILE A 152 VAL A 354 LEU A 339	None	1.23A	16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5es1	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4 (Homo sapiens)	5 / 5	LYS A  85 ILE A 106 VAL A 116 LEU A 185 ASP A 196	5RC  A4000 (-2.8A) None None None 5RC  A4000 (-3.6A)	1.17A	24.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5i3o	BMP-2-INDUCIBLE PROTEIN KINASE (Homo sapiens)	4 / 5	LYS A  79 ILE A  98 VAL A 109 LEU A 187	IDV  A 401 ( 4.8A) None None IDV  A 401 (-4.4A)	0.74A	25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5j5t	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3 (Homo sapiens)	4 / 5	LYS A  45 VAL A  74 LEU A 143 ASP A 154	6G2  A 901 ( 3.9A) None 6G2  A 901 (-4.7A) 6G2  A 901 (-3.4A)	0.94A	22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5myv	SRSF PROTEIN KINASE 2,SRSF PROTEIN KINASE 2 (Homo sapiens)	4 / 5	LYS A 121 VAL A 157 LEU A 232 ASP A 541	SO4  A 702 (-3.3A) DMS  A 717 (-4.3A) None DMS  A 717 (-4.3A)	0.97A	24.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5ulm	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5 (Homo sapiens)	4 / 5	LYS A 512 ILE A 520 LEU A 392 ASP A 399	None	0.99A	22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	5vef	SERINE/THREONINE-PRO TEIN KINASE PAK 4 (Homo sapiens)	4 / 5	ILE A 369 VAL A 379 LEU A 447 ASP A 458	None None M77  A 601 (-4.6A) M77  A 601 ( 3.5A)	1.17A	26.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6b3e	CYCLIN-DEPENDENT KINASE 12 (Homo sapiens)	4 / 5	ILE A 777 VAL A 787 LEU A 866 ASP A 877	None None CJM  A1102 (-4.4A) MG  A1101 (-2.5A)	0.91A	15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c7y	TYROSINE-PROTEIN KINASE JAK1 (Homo sapiens)	4 / 5	LYS A 908 ILE A 928 LEU A1010 ASP A1021	ADP  A1201 (-2.8A) None ADP  A1201 (-4.5A) MG  A1203 (-1.8A)	1.17A	17.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c7y	TYROSINE-PROTEIN KINASE JAK1 (Homo sapiens)	4 / 5	LYS A 908 ILE A 928 VAL A 938 LEU A1010	ADP  A1201 (-2.8A) None None ADP  A1201 (-4.5A)	0.83A	17.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 5	ILE A 110 VAL A 120 LEU A 189 ASP A 200	None	1.22A	11.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6c9d	SERINE/THREONINE-PRO TEIN KINASE MARK1,SERINE/THREONI NE-PROTEIN KINASE MARK1 (Homo sapiens)	4 / 5	LYS A  89 ILE A 110 VAL A 120 LEU A 189	None	1.00A	11.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6ccf	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 1 (Homo sapiens)	4 / 5	LYS A 157 VAL A 212 LEU A 282 ASP A 293	H1N  A 501 (-2.8A) H1N  A 501 (-4.9A) H1N  A 501 (-4.8A) H1N  A 501 (-3.5A)	1.10A	17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6cmj	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 2 (Homo sapiens)	5 / 5	LYS A 194 ILE A 239 VAL A 249 LEU A 319 ASP A 330	F6J  A 501 (-2.9A) None None F6J  A 501 (-4.5A) F6J  A 501 (-3.8A)	1.09A	14.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	6f3d	INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (Homo sapiens)	4 / 5	LYS A 213 VAL A 246 LEU A 318 ASP A 329	CJT  A 502 (-3.0A) None CJT  A 502 (-4.7A) CJT  A 502 ( 4.0A)	1.01A	15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1rjb	FL CYTOKINE RECEPTOR (Homo sapiens)	7 / 12	LEU A 616 GLY A 617 VAL A 624 ALA A 642 GLU A 661 TYR A 693 GLY A 697	None	0.88A	15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 TYR A 672 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A)	0.45A	18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	7 / 12	LEU A 344 VAL A 352 ALA A 367 GLU A 386 MET A 390 ALA A 417 GLY A 420	STU  A 100 (-3.8A) STU  A 100 (-4.8A) STU  A 100 (-3.2A) None None STU  A 100 (-3.7A) STU  A 100 (-3.5A)	0.47A	15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1zlt	SERINE/THREONINE-PRO TEIN KINASE CHK1 (Homo sapiens)	6 / 12	LEU A  15 VAL A  23 ALA A  36 GLU A  55 TYR A  86 GLY A  90	HYM  A 400 (-4.2A) HYM  A 400 (-4.3A) HYM  A 400 (-3.5A) None HYM  A 400 (-4.7A) None	0.44A	22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	7 / 12	LEU X  17 GLY X  18 ALA X  37 GLU X  54 MET X  58 TYR X  84 ALA X 147	STU  X 902 (-3.8A) STU  X 902 ( 3.7A) STU  X 902 (-3.1A) STU  X 902 ( 4.4A) None STU  X 902 (-4.6A) STU  X 902 ( 4.1A)	1.08A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	8 / 12	LEU X  17 VAL X  25 ALA X  37 GLU X  54 MET X  58 TYR X  84 GLY X  88 ALA X 147	STU  X 902 (-3.8A) STU  X 902 ( 4.8A) STU  X 902 (-3.1A) STU  X 902 ( 4.4A) None STU  X 902 (-4.6A) STU  X 902 (-3.5A) STU  X 902 ( 4.1A)	0.62A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2h8h	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (Homo sapiens)	6 / 12	LEU A 273 VAL A 281 ALA A 293 TYR A 340 GLY A 344 ALA A 403	H8H  A 534 (-3.8A) H8H  A 534 (-4.4A) H8H  A 534 (-3.2A) H8H  A 534 (-4.3A) H8H  A 534 (-3.3A) H8H  A 534 ( 4.0A)	0.63A	9.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2hak	SERINE/THREONINE-PRO TEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  67 ALA A  80 MET A 104 TYR A 131 ALA A 132 GLY A 135 ALA A 192	None	0.96A	14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2hk5	TYROSINE-PROTEIN KINASE HCK (Homo sapiens)	7 / 12	LEU A 251 VAL A 259 ALA A 271 GLU A 288 MET A 292 GLY A 322 ALA A 381	1BM  A 499 ( 3.7A) 1BM  A 499 ( 4.8A) 1BM  A 499 (-3.6A) 1BM  A 499 (-3.2A) 1BM  A 499 ( 3.8A) 1BM  A 499 (-3.5A) 1BM  A 499 ( 3.7A)	1.05A	15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2hz0	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	7 / 12	LEU A 248 VAL A 256 ALA A 269 GLU A 286 MET A 290 GLY A 321 ALA A 380	GIN  A 600 ( 4.6A) GIN  A 600 ( 4.7A) GIN  A 600 (-3.1A) GIN  A 600 (-3.6A) GIN  A 600 (-3.2A) None GIN  A 600 (-3.1A)	0.67A	16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2i0e	PROTEIN KINASE C-BETA II (Homo sapiens)	6 / 12	LEU A 348 VAL A 356 ALA A 369 GLU A 390 TYR A 422 ALA A 483	PDS  A 901 (-3.9A) PDS  A 901 (-4.2A) PDS  A 901 (-3.3A) None PDS  A 901 (-4.7A) PDS  A 901 (-3.4A)	0.70A	14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2og8	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK (Homo sapiens)	8 / 12	LEU A 251 PHE A 383 VAL A 259 ALA A 271 GLU A 288 MET A 292 GLY A 322 ALA A 381	None 1N8  A 501 ( 4.3A) None 1N8  A 501 ( 3.4A) 1N8  A 501 ( 3.6A) 1N8  A 501 ( 3.6A) 1N8  A 501 ( 3.5A) 1N8  A 501 ( 3.3A)	0.88A	20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2og8	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK (Homo sapiens)	8 / 12	LEU A 251 VAL A 259 ALA A 271 GLU A 288 MET A 292 TYR A 318 GLY A 322 ALA A 381	None None 1N8  A 501 ( 3.4A) 1N8  A 501 ( 3.6A) 1N8  A 501 ( 3.6A) 1N8  A 501 ( 3.7A) 1N8  A 501 ( 3.5A) 1N8  A 501 ( 3.3A)	0.73A	20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 GLY A 589 ALA A 614 GLU A 633 MET A 637 TYR A 665 GLY A 669	None	0.96A	24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	7 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 TYR A 665 GLY A 669	None	0.58A	24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2p4i	ANGIOPOIETIN-1 RECEPTOR (Homo sapiens)	6 / 12	VAL A 838 ALA A 853 TYR A 904 ALA A 905 GLY A 908 ALA A 981	MR9  A 301 (-4.6A) MR9  A 301 (-3.5A) MR9  A 301 (-3.8A) MR9  A 301 (-3.6A) MR9  A 301 ( 3.8A) MR9  A 301 (-3.2A)	0.69A	12.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2psq	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	11 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 GLU A 534 MET A 538 VAL A 564 TYR A 566 ALA A 567 GLY A 570 ALA A 643	None	0.53A	45.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2vd5	DMPK PROTEIN (Homo sapiens)	6 / 12	VAL A  85 ALA A  98 GLU A 119 TYR A 150 GLY A 154 ALA A 212	BI8  A1417 ( 4.7A) BI8  A1417 ( 3.8A) BI8  A1417 ( 4.9A) BI8  A1417 (-4.8A) None BI8  A1417 ( 4.1A)	0.77A	11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2x4f	MYOSIN LIGHT CHAIN KINASE FAMILY MEMBER 4 (Homo sapiens)	6 / 12	LEU A 112 VAL A 120 ALA A 133 MET A 155 TYR A 182 GLY A 186	16X  A1374 (-4.1A) 16X  A1374 (-4.8A) 16X  A1374 ( 3.8A) None 16X  A1374 (-4.1A) 16X  A1374 (-4.0A)	0.58A	14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2xik	SERINE/THREONINE PROTEIN KINASE 25 (Homo sapiens)	6 / 12	GLY A  27 ALA A  47 GLU A  66 TYR A  97 GLY A 101 ALA A 157	J60  A1294 ( 4.1A) J60  A1294 (-3.3A) None J60  A1294 (-4.5A) J60  A1294 ( 3.8A) J60  A1294 ( 4.2A)	0.77A	14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2xik	SERINE/THREONINE PROTEIN KINASE 25 (Homo sapiens)	6 / 12	VAL A  34 ALA A  47 GLU A  66 TYR A  97 GLY A 101 ALA A 157	J60  A1294 ( 4.9A) J60  A1294 (-3.3A) None J60  A1294 (-4.5A) J60  A1294 ( 3.8A) J60  A1294 ( 4.2A)	0.57A	14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2z8c	INSULIN RECEPTOR (Homo sapiens)	6 / 12	LEU A1002 VAL A1010 ALA A1028 GLU A1047 MET A1051 GLY A1082	S91  A   1 ( 4.1A) S91  A   1 ( 4.9A) S91  A   1 (-3.2A) None None S91  A   1 (-3.3A)	0.69A	13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3a62	RIBOSOMAL PROTEIN S6 KINASE BETA-1 (Homo sapiens)	6 / 12	LEU A  97 VAL A 105 ALA A 121 GLU A 143 TYR A 174 GLY A 178	STU  A 400 (-3.8A) STU  A 400 (-4.9A) STU  A 400 (-3.1A) STU  A 400 ( 4.3A) STU  A 400 (-4.7A) STU  A 400 ( 4.4A)	0.47A	13.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	9 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 GLU A 534 MET A 538 VAL A 564 TYR A 566 ALA A 567	M33  A1996 (-4.0A) M33  A1996 ( 3.8A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None None None M33  A1996 ( 4.7A) M33  A1996 (-3.8A)	1.02A	75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	9 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 MET A 538 VAL A 564 TYR A 566 ALA A 567 ALA A 643	M33  A1996 (-4.0A) M33  A1996 ( 3.8A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None None M33  A1996 ( 4.7A) M33  A1996 (-3.8A) None	0.93A	75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	9 / 12	LEU A 487 VAL A 495 ALA A 515 MET A 538 VAL A 564 TYR A 566 ALA A 567 GLY A 570 ALA A 643	M33  A1996 (-4.0A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None None M33  A1996 ( 4.7A) M33  A1996 (-3.8A) M33  A1996 ( 4.8A) None	0.46A	75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	GLY A 487 PHE A 489 VAL A 492 GLU A 531 MET A 535 VAL A 561 ALA A 640	None C4F  A   1 (-3.7A) None None C4F  A   1 ( 3.7A) C4F  A   1 ( 4.8A) C4F  A   1 (-3.6A)	1.34A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	12 / 12	LEU A 484 GLY A 485 PHE A 489 VAL A 492 ALA A 512 GLU A 531 MET A 535 VAL A 561 TYR A 563 ALA A 564 GLY A 567 ALA A 640	C4F  A   1 ( 3.9A) C4F  A   1 ( 4.5A) C4F  A   1 (-3.7A) None C4F  A   1 (-3.3A) None C4F  A   1 ( 3.7A) C4F  A   1 ( 4.8A) None C4F  A   1 (-3.5A) None C4F  A   1 (-3.6A)	0.50A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3d7u	TYROSINE-PROTEIN KINASE CSK (Homo sapiens)	6 / 12	VAL A 209 ALA A 220 GLU A 236 MET A 240 TYR A 268 GLY A 272	None	0.62A	15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3fe3	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3 (Homo sapiens)	7 / 12	VAL A  70 ALA A  83 MET A 107 TYR A 134 ALA A 135 GLY A 138 ALA A 195	None	0.83A	11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3hng	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	LEU A 833 VAL A 841 ALA A 859 GLU A 878 VAL A 909 TYR A 911 GLY A 915	8ST  A2001 ( 4.7A) 8ST  A2001 ( 4.6A) 8ST  A2001 ( 3.8A) 8ST  A2001 (-3.7A) 8ST  A2001 (-4.1A) 8ST  A2001 (-4.9A) None	0.23A	14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3iec	SERINE/THREONINE-PRO TEIN KINASE MARK2 (Homo sapiens)	7 / 12	VAL A  67 ALA A  80 MET A 104 TYR A 131 ALA A 132 GLY A 135 ALA A 192	None	0.71A	13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	7 / 12	LEU A  39 VAL A  47 ALA A  60 GLU A  80 TYR A 112 ALA A 113 GLY A 116	QUE  A   1 ( 3.8A) QUE  A   1 ( 4.6A) QUE  A   1 (-3.2A) QUE  A   1 (-3.1A) QUE  A   1 (-4.9A) QUE  A   1 (-3.9A) None	0.67A	12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3mdy	BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (Homo sapiens)	6 / 12	VAL A 218 ALA A 229 GLU A 244 TYR A 281 GLY A 285 ALA A 349	LDN  A   1 ( 4.8A) LDN  A   1 (-3.6A) None LDN  A   1 ( 4.8A) LDN  A   1 (-3.3A) LDN  A   1 ( 3.8A)	0.77A	12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	6 / 12	LEU A  49 VAL A  57 ALA A  70 GLU A  91 TYR A 122 GLY A 126	XFE  A 351 (-4.2A) XFE  A 351 ( 4.5A) XFE  A 351 (-3.2A) None None None	0.44A	15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3nuu	PKB-LIKE (Homo sapiens)	8 / 12	LEU A  88 VAL A  96 ALA A 109 GLU A 130 MET A 134 TYR A 161 ALA A 162 GLY A 165	JOZ  A 361 (-4.1A) JOZ  A 361 ( 4.7A) JOZ  A 361 (-3.4A) SO4  A   5 (-3.1A) None None JOZ  A 361 (-3.8A) None	0.56A	15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3qfv	CDC42BPB PROTEIN (Homo sapiens)	6 / 12	VAL A  90 ALA A 103 GLU A 124 TYR A 155 GLY A 159 ALA A 217	NM7  A 416 (-3.7A) NM7  A 416 ( 3.7A) EDO  A 417 (-4.0A) NM7  A 416 (-4.4A) None NM7  A 416 ( 4.5A)	0.76A	13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3s95	LIM DOMAIN KINASE 1 (Homo sapiens)	6 / 12	LEU A 345 GLU A 384 MET A 388 TYR A 415 GLY A 419 ALA A 477	STU  A   1 (-3.8A) STU  A   1 (-3.7A) None STU  A   1 (-4.7A) STU  A   1 (-3.6A) STU  A   1 ( 4.1A)	0.80A	14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3sxs	CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX (Homo sapiens)	6 / 12	LEU A 423 VAL A 431 ALA A 443 MET A 464 TYR A 491 GLY A 495	PP2  A   1 (-4.1A) PP2  A   1 (-4.5A) PP2  A   1 (-3.2A) PP2  A   1 ( 4.3A) PP2  A   1 ( 4.9A) PP2  A   1 ( 4.2A)	0.72A	14.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	9 / 12	LEU A 484 GLY A 485 ALA A 512 GLU A 531 MET A 535 VAL A 561 TYR A 563 ALA A 564 ALA A 640	07J  A   1 ( 4.3A) 07J  A   1 ( 4.9A) 07J  A   1 (-3.5A) 07J  A   1 (-3.8A) 07J  A   1 (-3.8A) 07J  A   1 (-4.7A) 07J  A   1 (-4.7A) 07J  A   1 (-3.8A) 07J  A   1 (-3.2A)	0.90A	59.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	10 / 12	LEU A 484 VAL A 492 ALA A 512 GLU A 531 MET A 535 VAL A 561 TYR A 563 ALA A 564 GLY A 567 ALA A 640	07J  A   1 ( 4.3A) 07J  A   1 (-4.0A) 07J  A   1 (-3.5A) 07J  A   1 (-3.8A) 07J  A   1 (-3.8A) 07J  A   1 (-4.7A) 07J  A   1 (-4.7A) 07J  A   1 (-3.8A) 07J  A   1 (-3.7A) 07J  A   1 (-3.2A)	0.36A	59.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	6 / 12	LEU A 361 VAL A 369 ALA A 382 GLU A 403 GLY A 439 ALA A 496	07U  A   1 ( 4.8A) 07U  A   1 (-4.8A) 07U  A   1 (-3.3A) 07U  A   1 ( 4.8A) None 07U  A   1 ( 4.0A)	0.79A	11.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3vid	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	6 / 12	LEU A 840 VAL A 848 ALA A 866 GLU A 885 VAL A 916 GLY A 922	4TT  A2001 ( 4.0A) 4TT  A2001 ( 4.5A) 4TT  A2001 (-3.5A) None None 4TT  A2001 (-3.7A)	0.29A	15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3w18	AURORA KINASE A (Homo sapiens)	7 / 12	LEU A 139 VAL A 147 ALA A 160 TYR A 212 ALA A 213 GLY A 216 ALA A 273	N13  A 501 (-3.7A) N13  A 501 ( 4.7A) N13  A 501 ( 4.1A) N13  A 501 (-4.4A) N13  A 501 (-3.7A) N13  A 501 (-3.5A) N13  A 501 ( 3.8A)	0.39A	13.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3wzd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 840 GLY A 841 VAL A 848 ALA A 866 GLU A 885 VAL A 916 GLY A 922	LEV  A1201 ( 3.8A) LEV  A1201 (-3.1A) LEV  A1201 ( 4.9A) LEV  A1201 (-3.5A) LEV  A1201 (-3.7A) LEV  A1201 ( 4.6A) LEV  A1201 (-3.6A)	0.37A	16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4af3	AURORA KINASE B (Homo sapiens)	7 / 12	LEU A  83 GLY A  84 PHE A  88 VAL A  91 TYR A 156 ALA A 157 GLY A 160	VX6  A 500 (-3.8A) VX6  A 500 ( 4.1A) VX6  A 500 (-3.4A) VX6  A 500 ( 4.8A) VX6  A 500 (-4.2A) VX6  A 500 (-3.7A) VX6  A 500 (-3.3A)	1.19A	13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4af3	AURORA KINASE B (Homo sapiens)	8 / 12	LEU A  83 GLY A  84 VAL A  91 ALA A 104 TYR A 156 ALA A 157 GLY A 160 ALA A 217	VX6  A 500 (-3.8A) VX6  A 500 ( 4.1A) VX6  A 500 ( 4.8A) VX6  A 500 (-3.4A) VX6  A 500 (-4.2A) VX6  A 500 (-3.7A) VX6  A 500 (-3.3A) VX6  A 500 ( 4.2A)	0.80A	13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4agd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 840 GLY A 841 PHE A1047 ALA A 866 GLU A 885 VAL A 916 GLY A 922	B49  A2000 (-3.7A) B49  A2000 ( 4.6A) B49  A2000 (-4.0A) B49  A2000 (-3.5A) None B49  A2000 (-4.8A) B49  A2000 ( 3.7A)	1.22A	15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4agd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 840 PHE A1047 VAL A 848 ALA A 866 GLU A 885 VAL A 916 GLY A 922	B49  A2000 (-3.7A) B49  A2000 (-4.0A) None B49  A2000 (-3.5A) None B49  A2000 (-4.8A) B49  A2000 ( 3.7A)	0.84A	15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4at3	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	6 / 12	LEU A 560 GLY A 561 PHE A 565 VAL A 568 ALA A 586 GLY A 639	LTI  A1839 ( 4.2A) LTI  A1839 ( 4.3A) LTI  A1839 (-3.5A) None LTI  A1839 (-3.3A) LTI  A1839 (-3.4A)	0.60A	12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4at3	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	6 / 12	LEU A 560 GLY A 561 VAL A 568 ALA A 586 TYR A 635 GLY A 639	LTI  A1839 ( 4.2A) LTI  A1839 ( 4.3A) None LTI  A1839 (-3.3A) LTI  A1839 (-4.7A) LTI  A1839 (-3.4A)	0.60A	12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4ckr	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	7 / 12	LEU A 616 GLY A 617 ALA A 653 GLU A 672 MET A 676 TYR A 703 ALA A 783	None None DI1  A1000 (-3.6A) DI1  A1000 (-3.8A) DI1  A1000 (-3.6A) DI1  A1000 (-4.0A) DI1  A1000 (-3.7A)	1.38A	16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4ckr	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	8 / 12	LEU A 616 PHE A 785 VAL A 624 ALA A 653 GLU A 672 MET A 676 TYR A 703 ALA A 783	None DI1  A1000 (-4.5A) DI1  A1000 (-4.8A) DI1  A1000 (-3.6A) DI1  A1000 (-3.8A) DI1  A1000 (-3.6A) DI1  A1000 (-4.0A) DI1  A1000 (-3.7A)	0.99A	16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4ckr	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	8 / 12	PHE A 785 VAL A 624 ALA A 653 GLU A 672 MET A 676 TYR A 703 GLY A 707 ALA A 783	DI1  A1000 (-4.5A) DI1  A1000 (-4.8A) DI1  A1000 (-3.6A) DI1  A1000 (-3.8A) DI1  A1000 (-3.6A) DI1  A1000 (-4.0A) None DI1  A1000 (-3.7A)	0.97A	16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4crs	SERINE/THREONINE-PRO TEIN KINASE N2 (Homo sapiens)	8 / 12	LEU A 663 VAL A 671 ALA A 684 GLU A 705 TYR A 739 ALA A 740 GLY A 743 ALA A 799	AGS  A1985 (-4.2A) AGS  A1985 (-4.6A) AGS  A1985 (-3.5A) None None AGS  A1985 (-3.9A) None AGS  A1985 ( 4.5A)	0.64A	11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4gv1	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	7 / 12	LEU A 156 VAL A 164 ALA A 177 GLU A 198 TYR A 229 ALA A 230 GLY A 233	0XZ  A 501 ( 4.1A) 0XZ  A 501 (-4.5A) 0XZ  A 501 (-3.3A) GOL  A 503 (-3.6A) 0XZ  A 501 ( 4.9A) 0XZ  A 501 (-3.7A) None	0.59A	13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4hvi	TYROSINE-PROTEIN KINASE JAK3 (Homo sapiens)	7 / 12	LEU A 828 VAL A 836 ALA A 853 GLU A 871 TYR A 904 GLY A 908 ALA A 966	19S  A1201 (-3.9A) 19S  A1201 (-4.4A) 19S  A1201 (-3.3A) None 19S  A1201 (-4.7A) 19S  A1201 ( 3.8A) 19S  A1201 ( 4.1A)	0.57A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4k11	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (Homo sapiens)	6 / 12	LEU A 273 VAL A 281 ALA A 293 TYR A 340 GLY A 344 ALA A 403	0J9  A 601 (-4.0A) 0J9  A 601 (-4.4A) 0J9  A 601 (-3.3A) 0J9  A 601 ( 4.7A) 0J9  A 601 ( 4.1A) 0J9  A 601 (-3.5A)	0.67A	10.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	10 / 12	LEU A 478 GLY A 479 ALA A 506 GLU A 525 MET A 529 VAL A 555 TYR A 557 ALA A 558 GLY A 561 ALA A 634	ACP  A 801 (-3.8A) ACP  A 801 (-3.4A) ACP  A 801 (-3.3A) ACP  A 801 ( 4.8A) None ACP  A 801 (-4.7A) None ACP  A 801 (-3.7A) ACP  A 801 ( 4.6A) None	0.83A	66.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	10 / 12	LEU A 478 VAL A 486 ALA A 506 GLU A 525 MET A 529 VAL A 555 TYR A 557 ALA A 558 GLY A 561 ALA A 634	ACP  A 801 (-3.8A) ACP  A 801 (-4.2A) ACP  A 801 (-3.3A) ACP  A 801 ( 4.8A) None ACP  A 801 (-4.7A) None ACP  A 801 (-3.7A) ACP  A 801 ( 4.6A) None	0.69A	66.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4l52	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7, TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 1 CHIMERA (Homo sapiens)	6 / 12	VAL A  50 ALA A  61 GLU A  77 TYR A 106 ALA A 107 GLY A 110	1UL  A 501 ( 4.9A) 1UL  A 501 (-3.1A) None 1UL  A 501 (-4.1A) 1UL  A 501 (-3.6A) 1UL  A 501 ( 3.7A)	0.67A	13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4lg4	SERINE/THREONINE-PRO TEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A  33 VAL A  41 ALA A  54 MET A  74 TYR A 101 ALA A 163	GOL  A 404 ( 3.6A) GOL  A 404 (-4.5A) GOL  A 404 ( 3.1A) None GOL  A 404 ( 4.9A) GOL  A 403 ( 3.0A)	0.70A	15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4lg4	SERINE/THREONINE-PRO TEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A  33 VAL A  41 ALA A  54 TYR A 101 GLY A 105 ALA A 163	GOL  A 404 ( 3.6A) GOL  A 404 (-4.5A) GOL  A 404 ( 3.1A) GOL  A 404 ( 4.9A) GOL  A 404 (-3.6A) GOL  A 403 ( 3.0A)	0.68A	15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4o27	SERINE/THREONINE-PRO TEIN KINASE 24 (Homo sapiens)	6 / 12	VAL B  38 ALA B  51 GLU B  70 TYR B 101 GLY B 105 ALA B 161	ADP  B 500 (-4.5A) ADP  B 500 (-3.3A) None ADP  B 500 ( 4.7A) None None	0.53A	13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4oli	NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (Homo sapiens)	6 / 12	LEU A 903 VAL A 911 ALA A 928 GLU A 947 TYR A 980 GLY A 984	2TT  A1202 (-3.5A) 2TT  A1202 (-4.5A) 2TT  A1202 ( 3.9A) None 2TT  A1202 (-4.6A) 2TT  A1202 (-3.4A)	0.69A	7.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	7 / 12	LEU A 386 VAL A 394 ALA A 407 GLU A 428 TYR A 460 GLY A 464 ALA A 521	PZW  A 801 (-3.9A) PZW  A 801 (-4.6A) PZW  A 801 (-3.5A) None None None PZW  A 801 ( 4.6A)	0.76A	11.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4rt7	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 GLY A 617 PHE A 830 ALA A 642 GLU A 661 TYR A 693 GLY A 697	P30  A1001 (-3.8A) None P30  A1001 (-3.9A) P30  A1001 (-3.4A) P30  A1001 (-3.6A) P30  A1001 (-4.1A) P30  A1001 (-3.4A)	1.16A	12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4rt7	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 PHE A 830 VAL A 624 ALA A 642 GLU A 661 TYR A 693 GLY A 697	P30  A1001 (-3.8A) P30  A1001 (-3.9A) None P30  A1001 (-3.4A) P30  A1001 (-3.6A) P30  A1001 (-4.1A) P30  A1001 (-3.4A)	0.75A	12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	6 / 12	LEU A 104 VAL A 112 ALA A 125 GLU A 146 TYR A 177 GLY A 181	ATP  A 501 ( 4.3A) ATP  A 501 (-4.0A) ATP  A 501 (-3.4A) None None None	0.50A	14.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xcu	FIBROBLAST GROWTH FACTOR RECEPTOR 4 (Homo sapiens)	8 / 12	LEU A 473 GLY A 474 VAL A 481 ALA A 501 GLU A 520 MET A 524 VAL A 550 ALA A 629	40M  A1002 ( 4.6A) None 40M  A1002 ( 4.5A) 40M  A1002 ( 4.1A) 40M  A1002 (-3.7A) 40M  A1002 (-3.8A) 40M  A1002 (-4.7A) 40M  A1002 (-3.0A)	1.00A	65.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xcu	FIBROBLAST GROWTH FACTOR RECEPTOR 4 (Homo sapiens)	9 / 12	LEU A 473 VAL A 481 ALA A 501 GLU A 520 MET A 524 VAL A 550 ALA A 553 GLY A 556 ALA A 629	40M  A1002 ( 4.6A) 40M  A1002 ( 4.5A) 40M  A1002 ( 4.1A) 40M  A1002 (-3.7A) 40M  A1002 (-3.8A) 40M  A1002 (-4.7A) 40M  A1002 (-3.7A) 40M  A1002 ( 3.7A) 40M  A1002 (-3.0A)	0.52A	65.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xey	TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	6 / 12	LEU B 267 VAL B 275 ALA B 288 MET B 309 GLY B 340 ALA B 399	1N1  B 601 (-3.7A) 1N1  B 601 ( 4.9A) 1N1  B 601 (-3.5A) 1N1  B 601 (-3.7A) 1N1  B 601 (-3.5A) 1N1  B 601 (-3.5A)	0.77A	13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	GLY A 617 PHE A 830 VAL A 624 ALA A 642 GLU A 661 MET A 665 TYR A 693	None P30  A1001 ( 4.1A) P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 (-3.1A) P30  A1001 (-4.4A) P30  A1001 ( 4.4A)	1.23A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 GLY A 617 PHE A 830 VAL A 624 ALA A 642 GLU A 661 TYR A 693	P30  A1001 (-4.0A) None P30  A1001 ( 4.1A) P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 (-3.1A) P30  A1001 ( 4.4A)	1.11A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 PHE A 830 VAL A 624 ALA A 642 GLU A 661 TYR A 693 GLY A 697	P30  A1001 (-4.0A) P30  A1001 ( 4.1A) P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 (-3.1A) P30  A1001 ( 4.4A) P30  A1001 (-3.5A)	0.80A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	PHE A 830 VAL A 624 ALA A 642 GLU A 661 MET A 665 TYR A 693 GLY A 697	P30  A1001 ( 4.1A) P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 (-3.1A) P30  A1001 (-4.4A) P30  A1001 ( 4.4A) P30  A1001 (-3.5A)	0.90A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4yff	SERINE/THREONINE-PRO TEIN KINASE TNNI3K (Homo sapiens)	6 / 12	VAL A 477 ALA A 488 GLU A 509 TYR A 541 GLY A 545 ALA A 605	None 4CV  A 801 (-3.5A) None 4CV  A 801 (-3.9A) 4CV  A 801 ( 4.0A) 4CV  A 801 ( 3.9A)	0.76A	12.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	9 / 12	LEU A 484 GLY A 485 ALA A 512 GLU A 531 MET A 535 VAL A 561 TYR A 563 ALA A 564 ALA A 640	38O  A1769 (-3.2A) 38O  A1769 ( 4.7A) 38O  A1769 (-3.6A) EDO  A1766 (-4.1A) EDO  A1766 (-3.5A) 38O  A1769 (-4.3A) 38O  A1769 (-4.2A) 38O  A1769 (-3.9A) EDO  A1766 ( 4.4A)	0.99A	78.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	10 / 12	LEU A 484 VAL A 492 ALA A 512 GLU A 531 MET A 535 VAL A 561 TYR A 563 ALA A 564 GLY A 567 ALA A 640	38O  A1769 (-3.2A) 38O  A1769 (-4.5A) 38O  A1769 (-3.6A) EDO  A1766 (-4.1A) EDO  A1766 (-3.5A) 38O  A1769 (-4.3A) 38O  A1769 (-4.2A) 38O  A1769 (-3.9A) 38O  A1769 (-3.4A) EDO  A1766 ( 4.4A)	0.42A	78.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5es1	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4 (Homo sapiens)	7 / 12	VAL A  70 ALA A  83 GLU A 103 TYR A 134 ALA A 135 GLY A 138 ALA A 195	5RC  A4000 (-4.6A) 5RC  A4000 (-3.6A) None 5RC  A4000 (-4.5A) 5RC  A4000 (-3.7A) 5RC  A4000 (-3.3A) 5RC  A4000 ( 3.9A)	0.87A	11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5f1z	NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (Homo sapiens)	6 / 12	LEU A 903 VAL A 911 ALA A 928 GLU A 947 TYR A 980 GLY A 984	5U3  A1200 (-3.8A) 5U3  A1200 ( 4.4A) 5U3  A1200 (-3.5A) None 5U3  A1200 (-4.5A) 5U3  A1200 (-3.2A)	0.55A	15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	7 / 12	LEU A 730 GLY A 731 ALA A 756 VAL A 804 TYR A 806 ALA A 807 GLY A 810	PP1  A2012 (-4.6A) PP1  A2012 ( 3.9A) PP1  A2012 (-3.2A) PP1  A2012 (-4.5A) None PP1  A2012 ( 3.5A) PTR  A 809 (-2.4A)	0.75A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 GLU A 775 VAL A 804 TYR A 806	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) PP1  A2012 (-3.5A) PP1  A2012 (-4.5A) None	0.54A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	7 / 12	LEU A 730 VAL A 738 ALA A 756 VAL A 804 TYR A 806 ALA A 807 GLY A 810	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) PP1  A2012 (-4.5A) None PP1  A2012 ( 3.5A) PTR  A 809 (-2.4A)	0.58A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5grn	PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (Homo sapiens)	7 / 12	LEU A 599 VAL A 607 ALA A 625 GLU A 644 MET A 648 TYR A 676 GLY A 680	748  A1001 (-3.8A) 748  A1001 ( 4.7A) 748  A1001 (-3.7A) 748  A1001 (-3.3A) 748  A1001 (-3.4A) 748  A1001 (-4.0A) 748  A1001 ( 4.0A)	0.64A	17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5grn	PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (Homo sapiens)	7 / 12	PHE A 837 VAL A 607 ALA A 625 GLU A 644 MET A 648 TYR A 676 GLY A 680	748  A1001 (-3.7A) 748  A1001 ( 4.7A) 748  A1001 (-3.7A) 748  A1001 (-3.3A) 748  A1001 (-3.4A) 748  A1001 (-4.0A) 748  A1001 ( 4.0A)	0.95A	17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1ak6	DESTRIN (Homo sapiens; Sus scrofa)	3 / 3	LYS A 112 LEU A 108 ASP A  79	None	0.87A	19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1hjv	CHITINASE-3 LIKE PROTEIN 1 (Homo sapiens)	3 / 3	LYS A 377 LEU A 354 ASP A  47	None	0.82A	11.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1zrz	PROTEIN KINASE C, IOTA (Homo sapiens)	3 / 3	LYS A 274 LEU A 376 ASP A 387	BI1  A1000 (-3.5A) BI1  A1000 (-4.8A) BI1  A1000 (-4.5A)	0.93A	13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2buj	SERINE/THREONINE-PRO TEIN KINASE 16 (Homo sapiens)	3 / 3	LYS A  49 LEU A 155 ASP A 166	STU  A1301 ( 4.0A) STU  A1301 ( 4.8A) None	0.90A	13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2dh3	4F2 CELL-SURFACE ANTIGEN HEAVY CHAIN (Homo sapiens)	3 / 3	LYS A 116 LEU A 298 ASP A 296	None	0.76A	11.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2vd5	DMPK PROTEIN (Homo sapiens)	3 / 3	LYS A 100 LEU A 202 ASP A 213	BI8  A1417 (-4.2A) BI8  A1417 (-4.8A) BI8  A1417 (-3.8A)	0.94A	11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2wnp	FICOLIN-1 (Homo sapiens)	3 / 3	LYS F 230 LEU F 262 ASP F 138	None	0.71A	15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2xik	SERINE/THREONINE PROTEIN KINASE 25 (Homo sapiens)	3 / 3	LYS A  49 LEU A 147 ASP A 158	None J60  A1294 (-4.8A) J60  A1294 ( 4.6A)	0.69A	14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2xsx	BETA-ENOLASE (Homo sapiens)	3 / 3	LYS A 120 LEU A 112 ASP A 378	None None EDO  A 511 (-4.3A)	0.86A	11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2y7j	PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM (Homo sapiens)	3 / 3	LYS A  53 LEU A 160 ASP A 171	None B49  A1294 (-4.4A) B49  A1294 (-4.2A)	0.67A	12.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	3 / 3	LYS A 514 LEU A 630 ASP A 641	None C4F  A   1 (-4.6A) C4F  A   1 (-4.5A)	0.72A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3iec	SERINE/THREONINE-PRO TEIN KINASE MARK2 (Homo sapiens)	3 / 3	LYS A  82 LEU A 182 ASP A 193	None	0.84A	13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	3 / 3	LYS A  62 LEU A 165 ASP A 179	QUE  A   1 (-4.1A) None QUE  A   1 (-2.9A)	0.82A	12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3s95	LIM DOMAIN KINASE 1 (Homo sapiens)	3 / 3	LYS A 368 LEU A 467 ASP A 478	STU  A   1 (-3.1A) STU  A   1 (-4.6A) STU  A   1 ( 4.2A)	0.76A	14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3sag	EXOSOME COMPONENT 10 (Homo sapiens)	3 / 3	LYS A 480 LEU A 216 ASP A 252	LYS  A 480 ( 0.0A) LEU  A 216 ( 0.6A) ASP  A 252 ( 0.6A)	0.84A	12.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	3 / 3	LYS A 514 LEU A 630 ASP A 641	07J  A   1 (-4.5A) 07J  A   1 ( 4.4A) 07J  A   1 (-4.7A)	0.58A	59.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3wzd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	3 / 3	LYS A 868 LEU A1035 ASP A1046	None LEV  A1201 (-4.8A) GOL  A1210 ( 3.4A)	0.42A	16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3zbf	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS (Homo sapiens)	3 / 3	LYS A1980 LEU A2086 ASP A2102	VGH  A3000 ( 4.7A) VGH  A3000 (-4.3A) None	0.89A	16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4at3	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	3 / 3	LYS A 588 LEU A 699 ASP A 710	None LTI  A1839 (-4.2A) None	0.85A	12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4aw5	EPHRIN TYPE-B RECEPTOR 4 (Homo sapiens)	3 / 3	LYS A 123 LEU A 223 ASP A 234	30K  A1365 (-3.8A) 30K  A1365 (-4.5A) 30K  A1365 (-3.3A)	0.81A	14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4bgq	CYCLIN-DEPENDENT KINASE-LIKE 5 (Homo sapiens)	3 / 3	LYS A  42 LEU A 142 ASP A 153	38R  A1000 (-3.4A) 38R  A1000 ( 4.5A) 38R  A1000 ( 4.2A)	0.80A	11.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4ks8	SERINE/THREONINE-PRO TEIN KINASE PAK 6 (Homo sapiens)	3 / 3	LYS A 436 LEU A 533 ASP A 544	None B49  A 701 (-4.5A) B49  A 701 (-4.6A)	0.80A	15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4o27	SERINE/THREONINE-PRO TEIN KINASE 24 (Homo sapiens)	3 / 3	LYS B  53 LEU B 151 ASP B 162	ADP  B 500 (-3.1A) ADP  B 500 (-4.7A) ADP  B 500 ( 3.4A)	0.94A	13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xbr	PROTEIN FAM212A,SERINE/THREO NINE-PROTEIN KINASE PAK 4 (Homo sapiens)	3 / 3	LYS A 350 LEU A 447 ASP A 458	ATP  A 601 (-2.8A) None ATP  A 601 ( 2.5A)	0.84A	16.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xcu	FIBROBLAST GROWTH FACTOR RECEPTOR 4 (Homo sapiens)	3 / 3	LYS A 503 LEU A 619 ASP A 630	40M  A1002 (-4.0A) 40M  A1002 (-4.5A) 40M  A1002 (-4.5A)	0.60A	65.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5j9z	EPIDERMAL GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	LYS A 745 LEU A 844 ASP A 855	6HJ  A1101 (-4.2A) 6HJ  A1101 ( 4.8A) 6HJ  A1101 (-4.3A)	0.69A	14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	LYS A  77 LEU A  85 ASP A 175	None None HC4  A 401 (-4.0A)	0.89A	12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5okt	CASEIN KINASE I ISOFORM DELTA (Homo sapiens)	3 / 3	LYS C  38 LEU C 135 ASP C 149	9XK  C 301 ( 4.6A) 9XK  C 301 (-4.6A) None	0.85A	29.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	3 / 3	LYS A  40 LEU A 139 ASP A 150	7LV  A 401 (-3.0A) 7LV  A 401 (-4.9A) 7LV  A 401 (-4.2A)	0.86A	14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5uuu	BETA-ADRENERGIC RECEPTOR KINASE 1 (Homo sapiens)	3 / 3	LYS A 170 LEU A  34 ASP A 534	None	0.91A	9.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5w7i	PALMITOYLTRANSFERASE ZDHHC17 (Homo sapiens)	3 / 3	LYS A 266 LEU A 229 ASP A 252	None	0.90A	18.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	6f3d	INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (Homo sapiens)	3 / 3	LYS A 213 LEU A 318 ASP A 329	CJT  A 502 (-3.0A) CJT  A 502 (-4.7A) CJT  A 502 ( 4.0A)	0.73A	34.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1rjb	FL CYTOKINE RECEPTOR (Homo sapiens)	7 / 12	LEU A 616 GLY A 617 VAL A 624 ALA A 642 LYS A 644 GLU A 661 GLY A 697	None	1.01A	15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 ( 3.8A)	0.48A	18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1u59	TYROSINE-PROTEIN KINASE ZAP-70 (Homo sapiens)	8 / 12	LEU A 344 VAL A 352 ALA A 367 LYS A 369 GLU A 386 MET A 390 ALA A 417 GLY A 420	STU  A 100 (-3.8A) STU  A 100 (-4.8A) STU  A 100 (-3.2A) STU  A 100 ( 4.7A) None None STU  A 100 (-3.7A) STU  A 100 (-3.5A)	0.68A	15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1zlt	SERINE/THREONINE-PRO TEIN KINASE CHK1 (Homo sapiens)	6 / 12	LEU A  15 VAL A  23 ALA A  36 LYS A  38 GLU A  55 GLY A  90	HYM  A 400 (-4.2A) HYM  A 400 (-4.3A) HYM  A 400 (-3.5A) HYM  A 400 (-3.2A) None None	0.49A	22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2a2a	DEATH-ASSOCIATED PROTEIN KINASE 2 (Homo sapiens)	6 / 12	LEU A  19 VAL A  27 ALA A  40 LYS A  42 GLU A  64 GLY A  99	None None GOL  A3001 (-3.5A) None None None	0.58A	12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2buj	SERINE/THREONINE-PRO TEIN KINASE 16 (Homo sapiens)	6 / 12	LEU A  26 VAL A  34 ALA A  47 LYS A  49 GLU A  65 GLY A 104	STU  A1301 (-4.2A) STU  A1301 (-4.8A) STU  A1301 (-3.6A) STU  A1301 ( 4.0A) None STU  A1301 ( 4.0A)	0.68A	13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	8 / 12	LEU X  17 VAL X  25 ALA X  37 LYS X  39 GLU X  54 MET X  58 GLY X  88 ALA X 147	STU  X 902 (-3.8A) STU  X 902 ( 4.8A) STU  X 902 (-3.1A) STU  X 902 (-3.1A) STU  X 902 ( 4.4A) None STU  X 902 (-3.5A) STU  X 902 ( 4.1A)	0.63A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2eu9	DUAL SPECIFICITY PROTEIN KINASE CLK3 (Homo sapiens)	7 / 12	LEU A 162 VAL A 170 ALA A 184 LYS A 186 GLU A 201 GLY A 240 ALA A 319	None	0.86A	12.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2hak	SERINE/THREONINE-PRO TEIN KINASE MARK1 (Homo sapiens)	7 / 12	VAL A  67 ALA A  80 LYS A  82 MET A 104 ALA A 132 GLY A 135 ALA A 192	None	1.01A	14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2hk5	TYROSINE-PROTEIN KINASE HCK (Homo sapiens)	6 / 12	LEU A 251 VAL A 259 ALA A 271 LYS A 273 GLU A 288 MET A 292	1BM  A 499 ( 3.7A) 1BM  A 499 ( 4.8A) 1BM  A 499 (-3.6A) 1BM  A 499 (-3.8A) 1BM  A 499 (-3.2A) 1BM  A 499 ( 3.8A)	0.73A	15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2hz0	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	7 / 12	LEU A 248 VAL A 256 ALA A 269 GLU A 286 MET A 290 GLY A 321 ALA A 380	GIN  A 600 ( 4.6A) GIN  A 600 ( 4.7A) GIN  A 600 (-3.1A) GIN  A 600 (-3.6A) GIN  A 600 (-3.2A) None GIN  A 600 (-3.1A)	0.65A	16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2hz0	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	7 / 12	LEU A 248 VAL A 256 ALA A 269 LYS A 271 GLU A 286 GLY A 321 ALA A 380	GIN  A 600 ( 4.6A) GIN  A 600 ( 4.7A) GIN  A 600 (-3.1A) GIN  A 600 (-3.6A) GIN  A 600 (-3.6A) None GIN  A 600 (-3.1A)	0.54A	16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2og8	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK (Homo sapiens)	9 / 12	LEU A 251 PHE A 383 VAL A 259 ALA A 271 LYS A 273 GLU A 288 MET A 292 GLY A 322 ALA A 381	None 1N8  A 501 ( 4.3A) None 1N8  A 501 ( 3.4A) 1N8  A 501 ( 3.4A) 1N8  A 501 ( 3.6A) 1N8  A 501 ( 3.6A) 1N8  A 501 ( 3.5A) 1N8  A 501 ( 3.3A)	0.88A	20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2ogv	MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR PRECURSOR (Homo sapiens)	6 / 12	LEU A 588 VAL A 596 ALA A 614 GLU A 633 MET A 637 GLY A 669	None	0.57A	24.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2psq	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	10 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 GLU A 534 MET A 538 VAL A 564 ALA A 567 GLY A 570 ALA A 643	None	0.62A	45.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2w4k	DEATH-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	6 / 12	LEU A  19 VAL A  27 ALA A  40 LYS A  42 GLU A  64 GLY A  99	ADP  A1303 ( 3.9A) ADP  A1303 (-4.0A) ADP  A1303 (-3.5A) ADP  A1303 (-2.7A) ADP  A1303 ( 4.8A) None	0.50A	16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2z8c	INSULIN RECEPTOR (Homo sapiens)	6 / 12	LEU A1002 VAL A1010 ALA A1028 LYS A1030 GLU A1047 MET A1051	S91  A   1 ( 4.1A) S91  A   1 ( 4.9A) S91  A   1 (-3.2A) S91  A   1 ( 4.2A) None None	0.67A	13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3a62	RIBOSOMAL PROTEIN S6 KINASE BETA-1 (Homo sapiens)	6 / 12	LEU A  97 VAL A 105 ALA A 121 LYS A 123 GLU A 143 GLY A 178	STU  A 400 (-3.8A) STU  A 400 (-4.9A) STU  A 400 (-3.1A) STU  A 400 ( 4.3A) STU  A 400 ( 4.3A) STU  A 400 ( 4.4A)	0.63A	13.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 GLU A 534 MET A 538 VAL A 564	M33  A1996 (-4.0A) M33  A1996 ( 3.8A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None None None	1.07A	75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	8 / 12	LEU A 487 GLY A 488 VAL A 495 ALA A 515 MET A 538 VAL A 564 ALA A 567 ALA A 643	M33  A1996 (-4.0A) M33  A1996 ( 3.8A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) None None M33  A1996 (-3.8A) None	0.94A	75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 487 VAL A 495 ALA A 515 LYS A 517 GLU A 534 MET A 538 VAL A 564	M33  A1996 (-4.0A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) M33  A1996 ( 4.5A) None None None	0.80A	75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3b2t	FIBROBLAST GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	9 / 12	LEU A 487 VAL A 495 ALA A 515 LYS A 517 MET A 538 VAL A 564 ALA A 567 GLY A 570 ALA A 643	M33  A1996 (-4.0A) M33  A1996 ( 4.7A) M33  A1996 (-3.3A) M33  A1996 ( 4.5A) None None M33  A1996 (-3.8A) M33  A1996 ( 4.8A) None	0.67A	75.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	GLY A 487 PHE A 489 VAL A 492 ALA A 512 MET A 535 VAL A 561 ALA A 640	None C4F  A   1 (-3.7A) None C4F  A   1 (-3.3A) C4F  A   1 ( 3.7A) C4F  A   1 ( 4.8A) C4F  A   1 (-3.6A)	1.37A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	11 / 12	LEU A 484 GLY A 485 PHE A 489 VAL A 492 ALA A 512 GLU A 531 MET A 535 VAL A 561 ALA A 564 GLY A 567 ALA A 640	C4F  A   1 ( 3.9A) C4F  A   1 ( 4.5A) C4F  A   1 (-3.7A) None C4F  A   1 (-3.3A) None C4F  A   1 ( 3.7A) C4F  A   1 ( 4.8A) C4F  A   1 (-3.5A) None C4F  A   1 (-3.6A)	0.61A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	11 / 12	LEU A 484 GLY A 485 PHE A 489 VAL A 492 ALA A 512 LYS A 514 GLU A 531 MET A 535 VAL A 561 ALA A 564 GLY A 567	C4F  A   1 ( 3.9A) C4F  A   1 ( 4.5A) C4F  A   1 (-3.7A) None C4F  A   1 (-3.3A) None None C4F  A   1 ( 3.7A) C4F  A   1 ( 4.8A) C4F  A   1 (-3.5A) None	0.79A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3d7u	TYROSINE-PROTEIN KINASE CSK (Homo sapiens)	6 / 12	VAL A 209 ALA A 220 LYS A 222 GLU A 236 MET A 240 GLY A 272	None	0.62A	15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3fe3	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3 (Homo sapiens)	7 / 12	VAL A  70 ALA A  83 LYS A  85 MET A 107 ALA A 135 GLY A 138 ALA A 195	None	0.88A	11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3hng	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	7 / 12	LEU A 833 VAL A 841 ALA A 859 LYS A 861 GLU A 878 VAL A 909 GLY A 915	8ST  A2001 ( 4.7A) 8ST  A2001 ( 4.6A) 8ST  A2001 ( 3.8A) 8ST  A2001 (-4.0A) 8ST  A2001 (-3.7A) 8ST  A2001 (-4.1A) None	0.31A	14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3iec	SERINE/THREONINE-PRO TEIN KINASE MARK2 (Homo sapiens)	7 / 12	VAL A  67 ALA A  80 LYS A  82 MET A 104 ALA A 132 GLY A 135 ALA A 192	None	0.71A	13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	6 / 12	LEU A  39 VAL A  47 ALA A  60 GLU A  80 ALA A 113 GLY A 116	QUE  A   1 ( 3.8A) QUE  A   1 ( 4.6A) QUE  A   1 (-3.2A) QUE  A   1 (-3.1A) QUE  A   1 (-3.9A) None	0.63A	12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	6 / 12	LEU A  39 VAL A  47 ALA A  60 LYS A  62 ALA A 113 GLY A 116	QUE  A   1 ( 3.8A) QUE  A   1 ( 4.6A) QUE  A   1 (-3.2A) QUE  A   1 (-4.1A) QUE  A   1 (-3.9A) None	0.58A	12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3mvj	CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	6 / 12	LEU A  49 VAL A  57 ALA A  70 LYS A  72 GLU A  91 GLY A 126	XFE  A 351 (-4.2A) XFE  A 351 ( 4.5A) XFE  A 351 (-3.2A) None None None	0.36A	15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3nuu	PKB-LIKE (Homo sapiens)	7 / 12	LEU A  88 VAL A  96 ALA A 109 GLU A 130 MET A 134 ALA A 162 GLY A 165	JOZ  A 361 (-4.1A) JOZ  A 361 ( 4.7A) JOZ  A 361 (-3.4A) SO4  A   5 (-3.1A) None JOZ  A 361 (-3.8A) None	0.57A	15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3nuu	PKB-LIKE (Homo sapiens)	7 / 12	LEU A  88 VAL A  96 ALA A 109 LYS A 111 GLU A 130 ALA A 162 GLY A 165	JOZ  A 361 (-4.1A) JOZ  A 361 ( 4.7A) JOZ  A 361 (-3.4A) SO4  A   5 (-2.8A) SO4  A   5 (-3.1A) JOZ  A 361 (-3.8A) None	0.46A	15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3nyo	G PROTEIN-COUPLED RECEPTOR KINASE 6 (Homo sapiens)	6 / 12	LEU A 192 VAL A 200 ALA A 213 LYS A 215 GLU A 234 GLY A 269	AMP  A 577 ( 4.3A) AMP  A 577 (-4.3A) AMP  A 577 (-3.4A) AMP  A 577 (-2.8A) None None	0.71A	10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3qfv	CDC42BPB PROTEIN (Homo sapiens)	6 / 12	VAL A  90 ALA A 103 LYS A 105 GLU A 124 GLY A 159 ALA A 217	NM7  A 416 (-3.7A) NM7  A 416 ( 3.7A) EDO  A 417 (-3.5A) EDO  A 417 (-4.0A) None NM7  A 416 ( 4.5A)	0.66A	13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3she	MAP KINASE-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	6 / 12	LEU A  50 VAL A  58 ALA A  71 LYS A  73 GLU A  84 GLY A 124	I85  A 350 (-3.7A) I85  A 350 (-4.9A) I85  A 350 (-3.3A) I85  A 350 (-2.8A) None I85  A 350 (-3.0A)	0.65A	11.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	10 / 12	LEU A 484 VAL A 492 ALA A 512 LYS A 514 GLU A 531 MET A 535 VAL A 561 ALA A 564 GLY A 567 ALA A 640	07J  A   1 ( 4.3A) 07J  A   1 (-4.0A) 07J  A   1 (-3.5A) 07J  A   1 (-4.5A) 07J  A   1 (-3.8A) 07J  A   1 (-3.8A) 07J  A   1 (-4.7A) 07J  A   1 (-3.8A) 07J  A   1 (-3.7A) 07J  A   1 (-3.2A)	0.37A	59.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3txo	PROTEIN KINASE C ETA TYPE (Homo sapiens)	7 / 12	LEU A 361 VAL A 369 ALA A 382 LYS A 384 GLU A 403 GLY A 439 ALA A 496	07U  A   1 ( 4.8A) 07U  A   1 (-4.8A) 07U  A   1 (-3.3A) 07U  A   1 (-3.0A) 07U  A   1 ( 4.8A) None 07U  A   1 ( 4.0A)	0.70A	11.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3vid	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 840 VAL A 848 ALA A 866 LYS A 868 GLU A 885 VAL A 916 GLY A 922	4TT  A2001 ( 4.0A) 4TT  A2001 ( 4.5A) 4TT  A2001 (-3.5A) None None None 4TT  A2001 (-3.7A)	0.41A	15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3w18	AURORA KINASE A (Homo sapiens)	7 / 12	LEU A 139 VAL A 147 ALA A 160 LYS A 162 ALA A 213 GLY A 216 ALA A 273	N13  A 501 (-3.7A) N13  A 501 ( 4.7A) N13  A 501 ( 4.1A) N13  A 501 (-2.9A) N13  A 501 (-3.7A) N13  A 501 (-3.5A) N13  A 501 ( 3.8A)	0.66A	13.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3wzd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	8 / 12	LEU A 840 GLY A 841 VAL A 848 ALA A 866 LYS A 868 GLU A 885 VAL A 916 GLY A 922	LEV  A1201 ( 3.8A) LEV  A1201 (-3.1A) LEV  A1201 ( 4.9A) LEV  A1201 (-3.5A) None LEV  A1201 (-3.7A) LEV  A1201 ( 4.6A) LEV  A1201 (-3.6A)	0.57A	16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4af3	AURORA KINASE B (Homo sapiens)	7 / 12	LEU A  83 GLY A  84 VAL A  91 ALA A 104 ALA A 157 GLY A 160 ALA A 217	VX6  A 500 (-3.8A) VX6  A 500 ( 4.1A) VX6  A 500 ( 4.8A) VX6  A 500 (-3.4A) VX6  A 500 (-3.7A) VX6  A 500 (-3.3A) VX6  A 500 ( 4.2A)	0.79A	13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4af3	AURORA KINASE B (Homo sapiens)	7 / 12	LEU A  83 VAL A  91 ALA A 104 LYS A 106 ALA A 157 GLY A 160 ALA A 217	VX6  A 500 (-3.8A) VX6  A 500 ( 4.8A) VX6  A 500 (-3.4A) VX6  A 500 (-3.3A) VX6  A 500 (-3.7A) VX6  A 500 (-3.3A) VX6  A 500 ( 4.2A)	0.80A	13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4agd	VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (Homo sapiens)	7 / 12	LEU A 840 PHE A1047 VAL A 848 ALA A 866 GLU A 885 VAL A 916 GLY A 922	B49  A2000 (-3.7A) B49  A2000 (-4.0A) None B49  A2000 (-3.5A) None B49  A2000 (-4.8A) B49  A2000 ( 3.7A)	0.83A	15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4at3	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	7 / 12	LEU A 560 GLY A 561 PHE A 565 VAL A 568 ALA A 586 LYS A 588 GLY A 639	LTI  A1839 ( 4.2A) LTI  A1839 ( 4.3A) LTI  A1839 (-3.5A) None LTI  A1839 (-3.3A) None LTI  A1839 (-3.4A)	0.69A	12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4ckr	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	9 / 12	LEU A 616 PHE A 785 VAL A 624 ALA A 653 LYS A 655 GLU A 672 MET A 676 GLY A 707 ALA A 783	None DI1  A1000 (-4.5A) DI1  A1000 (-4.8A) DI1  A1000 (-3.6A) DI1  A1000 (-3.9A) DI1  A1000 (-3.8A) DI1  A1000 (-3.6A) None DI1  A1000 (-3.7A)	0.90A	16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4crs	SERINE/THREONINE-PRO TEIN KINASE N2 (Homo sapiens)	8 / 12	LEU A 663 VAL A 671 ALA A 684 LYS A 686 GLU A 705 ALA A 740 GLY A 743 ALA A 799	AGS  A1985 (-4.2A) AGS  A1985 (-4.6A) AGS  A1985 (-3.5A) AGS  A1985 (-3.0A) None AGS  A1985 (-3.9A) None AGS  A1985 ( 4.5A)	0.64A	11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4eut	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	6 / 12	LEU A  15 VAL A  23 ALA A  36 LYS A  38 GLU A  55 GLY A  92	BX7  A 401 (-3.7A) BX7  A 401 (-4.4A) BX7  A 401 (-3.4A) BX7  A 401 ( 4.0A) None BX7  A 401 (-3.5A)	0.34A	17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4euu	SERINE/THREONINE-PRO TEIN KINASE TBK1 (Homo sapiens)	6 / 12	LEU A  15 VAL A  23 ALA A  36 LYS A  38 GLU A  55 GLY A  92	BX7  A 401 (-3.9A) BX7  A 401 ( 4.6A) BX7  A 401 (-3.4A) BX7  A 401 (-3.5A) None BX7  A 401 (-3.3A)	0.29A	18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4f4p	TYROSINE-PROTEIN KINASE SYK (Homo sapiens)	7 / 12	LEU A 377 VAL A 385 ALA A 400 LYS A 402 GLU A 420 MET A 424 ALA A 451	0SB  A 701 ( 3.9A) 0SB  A 701 (-4.0A) 0SB  A 701 (-3.3A) 0SB  A 701 ( 4.8A) None None 0SB  A 701 (-4.0A)	0.79A	15.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4gv1	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	7 / 12	LEU A 156 VAL A 164 ALA A 177 LYS A 179 GLU A 198 ALA A 230 GLY A 233	0XZ  A 501 ( 4.1A) 0XZ  A 501 (-4.5A) 0XZ  A 501 (-3.3A) GOL  A 503 ( 2.8A) GOL  A 503 (-3.6A) 0XZ  A 501 (-3.7A) None	0.65A	13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4hvi	TYROSINE-PROTEIN KINASE JAK3 (Homo sapiens)	7 / 12	LEU A 828 VAL A 836 ALA A 853 LYS A 855 GLU A 871 GLY A 908 ALA A 966	19S  A1201 (-3.9A) 19S  A1201 (-4.4A) 19S  A1201 (-3.3A) 19S  A1201 (-3.5A) None 19S  A1201 ( 3.8A) 19S  A1201 ( 4.1A)	0.50A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4hzs	ACTIVATED CDC42 KINASE 1 (Homo sapiens)	6 / 12	LEU A 132 VAL A 140 ALA A 156 LYS A 158 ALA A 208 GLY A 211	None	0.63A	15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4id7	ACTIVATED CDC42 KINASE 1 (Homo sapiens)	6 / 12	LEU A 132 VAL A 140 ALA A 156 LYS A 158 ALA A 208 GLY A 211	1G0  A 401 ( 4.5A) 1G0  A 401 (-4.4A) 1G0  A 401 (-3.6A) 1G0  A 401 (-3.7A) 1G0  A 401 (-3.8A) 1G0  A 401 ( 4.5A)	0.71A	19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4jxf	SERINE/THREONINE-PRO TEIN KINASE PLK4 (Homo sapiens)	7 / 12	LEU A  18 GLY A  19 VAL A  26 ALA A  39 LYS A  41 GLY A  95 ALA A 153	631  A 301 (-3.4A) 631  A 301 (-3.6A) 631  A 301 (-4.6A) 631  A 301 (-3.3A) 631  A 301 (-2.7A) 631  A 301 ( 3.7A) 631  A 301 (-3.4A)	0.80A	14.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	6 / 12	LEU A 478 GLY A 479 ALA A 506 ALA A 558 GLY A 561 ALA A 634	ACP  A 801 (-3.8A) ACP  A 801 (-3.4A) ACP  A 801 (-3.3A) ACP  A 801 (-3.7A) ACP  A 801 ( 4.6A) None	0.64A	66.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4k33	FIBROBLAST GROWTH FACTOR RECEPTOR 3 (Homo sapiens)	10 / 12	LEU A 478 VAL A 486 ALA A 506 LYS A 508 GLU A 525 MET A 529 VAL A 555 ALA A 558 GLY A 561 ALA A 634	ACP  A 801 (-3.8A) ACP  A 801 (-4.2A) ACP  A 801 (-3.3A) ACP  A 801 (-2.7A) ACP  A 801 ( 4.8A) None ACP  A 801 (-4.7A) ACP  A 801 (-3.7A) ACP  A 801 ( 4.6A) None	0.73A	66.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4l52	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7, TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 1 CHIMERA (Homo sapiens)	6 / 12	VAL A  50 ALA A  61 LYS A  63 GLU A  77 ALA A 107 GLY A 110	1UL  A 501 ( 4.9A) 1UL  A 501 (-3.1A) None None 1UL  A 501 (-3.6A) 1UL  A 501 ( 3.7A)	0.74A	13.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4o27	SERINE/THREONINE-PRO TEIN KINASE 24 (Homo sapiens)	6 / 12	VAL B  38 ALA B  51 LYS B  53 GLU B  70 GLY B 105 ALA B 161	ADP  B 500 (-4.5A) ADP  B 500 (-3.3A) ADP  B 500 (-3.1A) None None None	0.50A	13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4o38	CYCLIN-G-ASSOCIATED KINASE (Homo sapiens)	6 / 12	LEU A  46 VAL A  54 ALA A  67 LYS A  69 GLU A  85 GLY A 128	SIN  A 401 ( 3.9A) None SIN  A 401 ( 3.7A) None None SIN  A 401 (-3.5A)	0.55A	11.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	7 / 12	LEU A 386 VAL A 394 ALA A 407 LYS A 409 GLU A 428 GLY A 464 ALA A 521	PZW  A 801 (-3.9A) PZW  A 801 (-4.6A) PZW  A 801 (-3.5A) None None None PZW  A 801 ( 4.6A)	0.71A	11.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4ra4	PROTEIN KINASE C (Homo sapiens)	7 / 12	LEU A 345 VAL A 353 ALA A 366 LYS A 368 GLU A 387 GLY A 423 ALA A 480	3KZ  A 701 ( 4.1A) 3KZ  A 701 (-3.9A) 3KZ  A 701 (-3.4A) 3KZ  A 701 ( 4.7A) None None 3KZ  A 701 ( 4.8A)	0.92A	15.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4rt7	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 PHE A 830 VAL A 624 ALA A 642 LYS A 644 GLU A 661 GLY A 697	P30  A1001 (-3.8A) P30  A1001 (-3.9A) None P30  A1001 (-3.4A) P30  A1001 (-3.4A) P30  A1001 (-3.6A) P30  A1001 (-3.4A)	0.74A	12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4tnb	G PROTEIN-COUPLED RECEPTOR KINASE 5 (Homo sapiens)	6 / 12	LEU A 192 VAL A 200 ALA A 213 LYS A 215 GLU A 234 GLY A 268	SGV  A 601 (-4.1A) SGV  A 601 ( 4.6A) SGV  A 601 (-3.3A) SGV  A 601 ( 4.2A) None None	0.65A	9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4wb7	DNAJ HOMOLOG SUBFAMILY B MEMBER 1,CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA (Homo sapiens)	6 / 12	LEU A 104 VAL A 112 ALA A 125 LYS A 127 GLU A 146 GLY A 181	ATP  A 501 ( 4.3A) ATP  A 501 (-4.0A) ATP  A 501 (-3.4A) ATP  A 501 (-2.6A) None None	0.41A	14.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4wsq	AP2-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	7 / 12	LEU A  52 VAL A  60 ALA A  72 LYS A  74 GLU A  90 MET A  94 GLY A 132	KSA  A 405 ( 4.0A) KSA  A 405 ( 4.9A) KSA  A 405 (-3.2A) None None None KSA  A 405 (-3.5A)	0.92A	14.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xcu	FIBROBLAST GROWTH FACTOR RECEPTOR 4 (Homo sapiens)	10 / 12	LEU A 473 VAL A 481 ALA A 501 LYS A 503 GLU A 520 MET A 524 VAL A 550 ALA A 553 GLY A 556 ALA A 629	40M  A1002 ( 4.6A) 40M  A1002 ( 4.5A) 40M  A1002 ( 4.1A) 40M  A1002 (-4.0A) 40M  A1002 (-3.7A) 40M  A1002 (-3.8A) 40M  A1002 (-4.7A) 40M  A1002 (-3.7A) 40M  A1002 ( 3.7A) 40M  A1002 (-3.0A)	0.55A	65.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	GLY A 617 PHE A 830 ALA A 642 LYS A 644 GLU A 661 MET A 665 GLY A 697	None P30  A1001 ( 4.1A) P30  A1001 (-3.5A) P30  A1001 ( 4.0A) P30  A1001 (-3.1A) P30  A1001 (-4.4A) P30  A1001 (-3.5A)	1.18A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 GLY A 617 PHE A 830 ALA A 642 LYS A 644 GLU A 661 GLY A 697	P30  A1001 (-4.0A) None P30  A1001 ( 4.1A) P30  A1001 (-3.5A) P30  A1001 ( 4.0A) P30  A1001 (-3.1A) P30  A1001 (-3.5A)	1.17A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	LEU A 616 PHE A 830 VAL A 624 ALA A 642 LYS A 644 GLU A 661 GLY A 697	P30  A1001 (-4.0A) P30  A1001 ( 4.1A) P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 ( 4.0A) P30  A1001 (-3.1A) P30  A1001 (-3.5A)	0.81A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xuf	RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 (Homo sapiens)	7 / 12	PHE A 830 VAL A 624 ALA A 642 LYS A 644 GLU A 661 MET A 665 GLY A 697	P30  A1001 ( 4.1A) P30  A1001 ( 4.8A) P30  A1001 (-3.5A) P30  A1001 ( 4.0A) P30  A1001 (-3.1A) P30  A1001 (-4.4A) P30  A1001 (-3.5A)	0.90A	14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4yff	SERINE/THREONINE-PRO TEIN KINASE TNNI3K (Homo sapiens)	6 / 12	VAL A 477 ALA A 488 LYS A 490 GLU A 509 GLY A 545 ALA A 605	None 4CV  A 801 (-3.5A) 4CV  A 801 (-3.9A) None 4CV  A 801 ( 4.0A) 4CV  A 801 ( 3.9A)	0.64A	12.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	7 / 12	LEU A 484 GLY A 485 ALA A 512 MET A 535 VAL A 561 ALA A 564 ALA A 640	38O  A1769 (-3.2A) 38O  A1769 ( 4.7A) 38O  A1769 (-3.6A) EDO  A1766 (-3.5A) 38O  A1769 (-4.3A) 38O  A1769 (-3.9A) EDO  A1766 ( 4.4A)	1.07A	78.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	10 / 12	LEU A 484 VAL A 492 ALA A 512 LYS A 514 GLU A 531 MET A 535 VAL A 561 ALA A 564 GLY A 567 ALA A 640	38O  A1769 (-3.2A) 38O  A1769 (-4.5A) 38O  A1769 (-3.6A) 38O  A1769 ( 3.1A) EDO  A1766 (-4.1A) EDO  A1766 (-3.5A) 38O  A1769 (-4.3A) 38O  A1769 (-3.9A) 38O  A1769 (-3.4A) EDO  A1766 ( 4.4A)	0.52A	78.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5es1	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4 (Homo sapiens)	7 / 12	VAL A  70 ALA A  83 LYS A  85 GLU A 103 ALA A 135 GLY A 138 ALA A 195	5RC  A4000 (-4.6A) 5RC  A4000 (-3.6A) 5RC  A4000 (-2.8A) None 5RC  A4000 (-3.7A) 5RC  A4000 (-3.3A) 5RC  A4000 ( 3.9A)	0.76A	11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5f1z	NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (Homo sapiens)	6 / 12	LEU A 903 VAL A 911 ALA A 928 LYS A 930 GLU A 947 GLY A 984	5U3  A1200 (-3.8A) 5U3  A1200 ( 4.4A) 5U3  A1200 (-3.5A) None None 5U3  A1200 (-3.2A)	0.67A	15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 LYS A 758 GLU A 775 VAL A 804	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) PP1  A2012 (-4.1A) PP1  A2012 (-3.5A) PP1  A2012 (-4.5A)	0.44A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 LYS A 758 VAL A 804 ALA A 807	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) PP1  A2012 (-4.1A) PP1  A2012 (-4.5A) PP1  A2012 ( 3.5A)	0.56A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5fm2	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET (Homo sapiens)	6 / 12	LEU A 730 VAL A 738 ALA A 756 VAL A 804 ALA A 807 GLY A 810	PP1  A2012 (-4.6A) PP1  A2012 (-4.4A) PP1  A2012 (-3.2A) PP1  A2012 (-4.5A) PP1  A2012 ( 3.5A) PTR  A 809 (-2.4A)	0.63A	13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5grn	PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (Homo sapiens)	7 / 12	LEU A 599 VAL A 607 ALA A 625 LYS A 627 GLU A 644 MET A 648 GLY A 680	748  A1001 (-3.8A) 748  A1001 ( 4.7A) 748  A1001 (-3.7A) 748  A1001 (-4.0A) 748  A1001 (-3.3A) 748  A1001 (-3.4A) 748  A1001 ( 4.0A)	0.59A	17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5grn	PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA (Homo sapiens)	7 / 12	PHE A 837 VAL A 607 ALA A 625 LYS A 627 GLU A 644 MET A 648 GLY A 680	748  A1001 (-3.7A) 748  A1001 ( 4.7A) 748  A1001 (-3.7A) 748  A1001 (-4.0A) 748  A1001 (-3.3A) 748  A1001 (-3.4A) 748  A1001 ( 4.0A)	0.88A	17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1zlt	SERINE/THREONINE-PRO TEIN KINASE CHK1 (Homo sapiens)	3 / 3	TYR A  86 LEU A 137 ASP A 148	HYM  A 400 (-4.7A) HYM  A 400 (-4.5A) HYM  A 400 (-3.9A)	0.70A	22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2dq7	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (Homo sapiens)	3 / 3	TYR X  84 LEU X 137 ASP X 148	STU  X 902 (-4.6A) STU  X 902 (-4.4A) STU  X 902 (-3.6A)	0.64A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2h8h	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (Homo sapiens)	3 / 3	TYR A 340 LEU A 393 ASP A 404	H8H  A 534 (-4.3A) H8H  A 534 (-4.5A) H8H  A 534 (-4.2A)	0.62A	9.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2qyk	CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE HSPDE4A10 (Homo sapiens)	3 / 3	TYR A 371 LEU A 375 ASP A 323	NPV  A   3 (-4.4A) None None	0.87A	12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2vd5	DMPK PROTEIN (Homo sapiens)	3 / 3	TYR A 150 LEU A 202 ASP A 213	BI8  A1417 (-4.8A) BI8  A1417 (-4.8A) BI8  A1417 (-3.8A)	0.84A	11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2xik	SERINE/THREONINE PROTEIN KINASE 25 (Homo sapiens)	3 / 3	TYR A  97 LEU A 147 ASP A 158	J60  A1294 (-4.5A) J60  A1294 (-4.8A) J60  A1294 ( 4.6A)	0.70A	14.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3c4f	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	3 / 3	TYR A 563 LEU A 630 ASP A 641	None C4F  A   1 (-4.6A) C4F  A   1 (-4.5A)	0.31A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3d7u	TYROSINE-PROTEIN KINASE CSK (Homo sapiens)	3 / 3	TYR A 268 LEU A 321 ASP A 332	None	0.59A	15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3g2f	BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-2 (Homo sapiens)	3 / 3	TYR A 281 LEU A 340 ASP A 351	None ADP  A 900 (-4.6A) ADP  A 900 ( 2.7A)	0.77A	13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3gbj	KIF13B PROTEIN (Homo sapiens)	3 / 3	TYR A 182 LEU A 171 ASP A 163	None	0.75A	11.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3jar	MICROTUBULE-ASSOCIAT ED PROTEIN RP/EB FAMILY MEMBER 3 (Homo sapiens)	3 / 3	TYR N 124 LEU N  51 ASP N 116	None	0.85A	20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3kul	EPHRIN TYPE-A RECEPTOR 8 (Homo sapiens)	3 / 3	TYR A 715 LEU A 767 ASP A 778	GOL  A 403 (-4.1A) None None	0.59A	13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3lm5	SERINE/THREONINE-PRO TEIN KINASE 17B (Homo sapiens)	3 / 3	TYR A 112 LEU A 165 ASP A 179	QUE  A   1 (-4.9A) None QUE  A   1 (-2.9A)	0.71A	12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3mdy	BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (Homo sapiens)	3 / 3	TYR A 281 LEU A 339 ASP A 350	LDN  A   1 ( 4.8A) LDN  A   1 (-4.5A) LDN  A   1 (-3.9A)	0.77A	12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3mos	TRANSKETOLASE (Homo sapiens)	3 / 3	TYR A  83 LEU A  73 ASP A 183	None EDO  A 627 (-4.4A) TPP  A 700 ( 4.5A)	0.84A	7.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3ner	CYTOCHROME B5 TYPE B (Homo sapiens)	3 / 3	TYR A   6 LEU A  84 ASP A  53	None	0.79A	28.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3ntc	FAB HEAVY CHAIN FAB LIGHT CHAIN (Homo sapiens; Mus musculus)	3 / 3	TYR H 102 LEU L  46 ASP L  91	None None EDO  H 220 ( 4.5A)	0.61A	18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3s95	LIM DOMAIN KINASE 1 (Homo sapiens)	3 / 3	TYR A 415 LEU A 467 ASP A 478	STU  A   1 (-4.7A) STU  A   1 (-4.6A) STU  A   1 ( 4.2A)	0.64A	14.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3tt0	BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	3 / 3	TYR A 563 LEU A 630 ASP A 641	07J  A   1 (-4.7A) 07J  A   1 ( 4.4A) 07J  A   1 (-4.7A)	0.52A	59.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4bgq	CYCLIN-DEPENDENT KINASE-LIKE 5 (Homo sapiens)	3 / 3	TYR A  91 LEU A 142 ASP A 153	38R  A1000 (-4.8A) 38R  A1000 ( 4.5A) 38R  A1000 ( 4.2A)	0.80A	11.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4crs	SERINE/THREONINE-PRO TEIN KINASE N2 (Homo sapiens)	3 / 3	TYR A 739 LEU A 789 ASP A 800	None AGS  A1985 (-4.8A) AGS  A1985 ( 3.3A)	0.78A	11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4hvi	TYROSINE-PROTEIN KINASE JAK3 (Homo sapiens)	3 / 3	TYR A 904 LEU A 956 ASP A 967	19S  A1201 (-4.7A) 19S  A1201 (-4.5A) 19S  A1201 ( 4.1A)	0.86A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4k11	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (Homo sapiens)	3 / 3	TYR A 340 LEU A 393 ASP A 404	0J9  A 601 ( 4.7A) 0J9  A 601 (-4.5A) 0J9  A 601 (-3.1A)	0.69A	10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4p2k	EPHRIN TYPE-A RECEPTOR 2 (Homo sapiens)	3 / 3	TYR A 694 LEU A 746 ASP A 757	None	0.58A	13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4q9z	HUMAN PROTEIN KINASE C THETA (Homo sapiens)	3 / 3	TYR A 460 LEU A 511 ASP A 522	None PZW  A 801 (-4.8A) PZW  A 801 (-3.2A)	0.60A	11.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4um8	INTEGRIN BETA-6 (Homo sapiens)	3 / 3	TYR B 120 LEU B 155 ASP B 202	None	0.79A	7.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4wfs	TRNA-DIHYDROURIDINE( 20) SYNTHASE [NAD(P)+]-LIKE (Homo sapiens)	3 / 3	TYR A 270 LEU A  25 ASP A  64	None	0.81A	13.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4wjl	INACTIVE DIPEPTIDYL PEPTIDASE 10 (Homo sapiens)	3 / 3	TYR A 767 LEU A 774 ASP A 585	None	0.82A	8.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	4xgm	MITOCHONDRIAL RIBONUCLEASE P PROTEIN 3 (Homo sapiens)	3 / 3	TYR A 307 LEU A 279 ASP A 561	None	0.61A	13.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5a46	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	3 / 3	TYR A 563 LEU A 630 ASP A 641	38O  A1769 (-4.2A) 38O  A1769 (-4.6A) 38O  A1769 (-4.0A)	0.46A	78.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5es1	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4 (Homo sapiens)	3 / 3	TYR A 134 LEU A 185 ASP A 196	5RC  A4000 (-4.5A) None 5RC  A4000 (-3.6A)	0.89A	11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5idn	CYCLIN-DEPENDENT KINASE 8 (Homo sapiens)	3 / 3	TYR A  99 LEU A 158 ASP A 173	6A7  A 401 (-4.9A) 6A7  A 401 (-4.8A) FMT  A 403 ( 3.3A)	0.80A	13.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5jpn	COMPLEMENT C4-A (Homo sapiens)	3 / 3	TYR B 977 LEU B1362 ASP B 965	PBM  B1515 ( 4.9A) None None	0.85A	7.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5u7q	RHO-ASSOCIATED PROTEIN KINASE 2 (Homo sapiens)	3 / 3	TYR A 171 LEU A 221 ASP A 232	None	0.67A	12.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5vi6	HISTONE DEACETYLASE 8 (Homo sapiens)	3 / 3	TYR A 306 LEU A 179 ASP A 233	EDO  A 407 ( 3.3A) None None	0.71A	10.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5wdh	KINESIN-LIKE PROTEIN KIFC1 (Homo sapiens)	3 / 3	TYR A 402 LEU A 394 ASP A 375	None	0.82A	13.92